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ABSTRACT 
Inflammatory bowel diseases (IBD), such as ulcerative colitis (UC), are causes of chronic 
morbidity that significantly reduce physical functioning and decrease quality of life in afflicted 
patients. It is well established that pharmacological anti-inflammatory therapies, aimed to 
decrease colon inflammation, can attenuate symptoms of UC but their efficacy is not complete 
and their side effects can be debilitating. Preliminary studies have shown that there is a positive 
correlation between high levels of physical activity, reduced inflammatory biomarkers, and 
inflammatory-related disease activity indices. Moderate exercise has been shown to be well 
tolerated during mild to moderate chronic disease activity and promotes improvements in quality 
of life, muscle function, bone mineral density, stress management and body composition. This 
research has been conducted in clinical human studies, making it difficult to explore potential 
mechanisms through which exercise exerts protective effects. Thus, the purpose of our studies 
are to examine prior exercise training (30 sessions of treadmill-FTR and 30 days of voluntary 
wheel running-VWR) effects on morbidity and inflammation in a dextran sodium sulfate (DSS)-
induced colitis model in C57Bl/6J mice. We hypothesized that FTR and VWR would improve 
indices of morbidity and inflammation during colitis.  
We observed the effects of DSS-induced colitis during a recovery study as mice were 
euthanized and tissues were harvested on days 6, 8 (disease peak) and 12 in the FTR study and 
day 8 (disease peak) in the VWR study. We examined indices of morbidity (body weight, food 
and fluid intake, diarrhea incidence, fecal blood) and colonic inflammation (gene expression and 
histopathology). Contrary to our initial hypothesis, we found that moderate FTR intensified 
colonic inflammation as measured by significant (p < 0.05) increases in pro-inflammatory gene 
expression at disease peak (Day 8). While DSS-treated mice exhibited reductions in food and 
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fluid intake, and body weight, FTR did not significantly exacerbate these symptoms at least 
through Day 12. Histological assessment confirmed the presence of inflammation and colon 
damage at Day 6, 8, and 12. Surprisingly, during the 12 day study we observed 3 deaths all in the 
FTR/DSS group which further confirmed the severity of the inflammatory response exhibited in 
FTR mice. FTR (in the absence of DSS) increased expression of CCL6 indicating that FTR may 
increase gut immune surveillance and may be a potential cause of the exacerbated inflammatory 
response. Immunohistochemical analysis revealed that the number of colonic macrophages 
increased in FTR mice after training. Therefore we concluded that FTR exacerbates 
inflammation and causes mortality in this mouse model of colitis and training. Our results 
demonstrating that FTR resulted in adrenal hypertrophy and thymic involution indicate that, 
while this training model has demonstrated many physiological benefits, it may be a chronic 
stressor.  
In contrast, we observed that VWR significantly reduced morbidity and colonic 
inflammation in DSS treated mice. This effect was manifest as a significantly lower colon 
inflammatory burden at disease peak and a faster recovery in body weight, food, and fluid intake 
in VWR mice. Further, the abundance of colonic lactobacilli was greater in VWR control mice, 
possibly indicative of an anti-inflammatory mechanism we discussed herein. It is well known 
that VWR elicits anti-inflammatory effects in many different body compartments that are 
immunologically challenged (e.g. adipose tissue and brain) and we add the colon to this list with 
the data obtained with a mouse model of DSS induced colitis.  
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CHAPTER 1 
 INTRODUCTION 
1.1 Significance 
Inflammatory bowel diseases (IBD), such as ulcerative colitis (UC), are causes of chronic 
morbidity that significantly reduce physical functioning and quality of life in afflicted patients. 
UC is an inflammatory bowel disease characterized by the influx of immune cells into the colon 
mucosa in response to endogenous and foreign intestinal microbiota. Immune cell infiltration 
stimulates the production of pro-inflammatory cytokines, which promote a chronic inflammatory 
state, instigating clinical symptoms including: colon ulcers, rectal bleeding, diarrhea, abdominal 
pain, and an overall altered emotional well-being (1). Furthermore, UC significantly increases 
the risk of developing inflammatory colorectal cancer later in life (2). It is well established that 
anti-inflammatory therapies, aimed to decrease colon inflammation, attenuate the symptoms of 
UC in humans and mouse models of the disease (4). Anti-inflammatory pharmaceutical 
treatments, such as corticosteroids, are beneficial in reducing symptoms, but their efficacy is not 
complete.  Therefore, from a public health perspective, investigation of adjunct anti-
inflammatory therapies is of prime importance, as it could assist in reducing clinical symptoms, 
hospitalizations, improve quality of life, and reduce the risk of colorectal cancer.  
Exercise has been suggested as this adjunct anti-inflammatory therapy. Preliminary 
studies have shown that moderate intensity exercise training reduces the symptoms of IBD, 
improving quality of life in IBD patients (3) and there is a positive correlation between physical 
activity, reduced inflammatory biomarkers and colon disease activity indices (4). This research 
has been conducted in clinical human studies, making it difficult to explore potential 
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mechanisms through which exercise exerts protective effects. Exercise guidelines for patients 
with IBD were published in 1998 and were based upon the benefits for healthy persons (5) even 
though there were no research studies that investigated the role of exercise in IBD patients (6). It 
is well known that severe, exhaustive exercise can cause debilitating gastrointestinal symptoms 
(7) and professional and amateur athletes who have been diagnosed with IBD at different time 
points in their careers suggest that chronic exercise before diagnoses is not a protective factor for 
IBD onset (6). However, moderately intense activity has been shown to be well tolerated during 
mild to moderate disease activity and promotes improvements in quality of life, muscle function, 
bone mineral density, stress management, and body composition (6). Accordingly, researchers 
have shown that treadmill and voluntary wheel exercise training can improve immune function 
and is anti-inflammatory in the gut (8-10). However, there is inadequate research on the effects 
of exercise training on immune responses during an inflammatory insult such as ulcerative 
colitis.  
Our preliminary results showed that moderate intensity forced treadmill training (FTR) 
exacerbates dextran sodium sulfate (DSS)-induced colitis. Therefore, the specific aims of this 
research are to elucidate potential mechanisms of exercise training induced adaptations that may 
responsible for a) exacerbating colitis in treadmill trained mice while b) examining the effects of 
voluntary wheel training in our model of DSS colitis. This research is important because it has 
the potential to: 1) challenge the validity of the current public health recommendations regarding 
daily physical activity in patients with ulcerative colitis, 2) help determine adjunct treatment 
options for inflammatory bowel diseases, which ultimately reduce hospitalizations and health 
care costs, and 3) yield potential therapeutic targets which may prevent the exacerbation of IBD 
in physically active individuals.  
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1.2 Specific Aims 
The long-term goal of this research is to elucidate the mechanism(s) through which 
exercise affects colon inflammation and inflammatory bowel disease pathophysiology. This 
study, the first to examine the role of treadmill (FTR) and voluntary wheel (VWR) exercise 
training on inflammation, morbidity, and mortality in dextran sodium sulfate induced colitis in 
mice and has three specific aims that are presented below. A brief rationale, methods, 
hypotheses, expected results, and alternative hypotheses are presented below. A full description 
of the study methodology, including experimental design and statistical analysis, can be found in 
CHAPTER 3. 
1.2.1 Specific Aim 1 
Does moderate treadmill exercise training increase the homeostatic population of 
innate intestinal immune cells (macrophages)? If so, this could be a potential mechanism 
that contributes to the exacerbated inflammatory response to DSS-induced colitis in forced 
treadmill trained mice.  
We believe that FTR animals have an exacerbated immune response due to an increase in 
resident effector innate immune cell presence (macrophages) within the colon. Since we have 
witnessed an increase in chemokine CCL6 gene expression, a chemokine whose purpose is to 
activate and recruit effector innate immune cells such as macrophages (11), we hypothesize that 
FTR exacerbates the inflammatory response by increasing homeostatic macrophage populations 
in the colon. In this experiment, we will be performing immunohistochemistry (IHC) in colon 
sections to determine macrophage cell presence. For this study, 8-10 week old C57Bl/6J male 
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mice performed forced treadmill exercise for 6 weeks. Twenty-four hours after the last exercise 
session, mice were euthanized and colons were harvested. A portion of the distal colon was 
preserved in 10% buffered formalin and subsequently processed for IHC analysis to probe for 
macrophage (F4/80) presence.   
An increase in the number of effector immune cells, while increasing the immuno-
surveillance capacity in this tissue, could explain the more aggressive pro-inflammatory cytokine 
profile to DSS as more immune cells would be available to participate in the response. If this 
result is observed then we can conclude that, as a consequence of more resident effector cells 
(e.g. macrophages), the exacerbated pro-inflammatory immune response is a factor of more cells 
being present and participating in the immune response. If we find that there is no quantifiable 
difference in these innate immune cells in intestinal sections, we will conclude that an increase in 
resident innate immune cells, as a result of forced exercise training, does not explain the 
aggressive immune response in colitis. Alternative methodology of quantifying these cell 
populations and their activation state or sensitivity to stimulation in the colon may be necessary 
(e.g. flow cytometry). In this study, the number of animals and resources required to perform 
colonic immune cell analysis by flow cytometry is not feasible and would be proposed in future 
studies.  
1.2.2 Specific Aim 2 
Does moderate treadmill exercise training and DSS-induced colitis reduce the 
population of beneficial bacteria (Genus Lactobacillus) in the colon and alter intestinal 
microbial characteristics?  
5 
 
We know that intestinal epithelial cells participate in mucosal barrier immunity by secreting 
CCL6, which has antibacterial function and the capability to bind intestinal microbes (12). Thus, 
the FTR adaptation witnessed in our preliminary findings (↑ CCL6 gene expression) could 
potentially affect characteristics of the microbiome. We know that intestinal microbiota are 
sensitive to psychological (13) and physiological (diet and fasting) (14) challenges that can also 
alter gut immune responses to pathogens (15). Microbes are necessary for the development of the 
intestinal immune system and prime immune cell activity in the gut (16). For example, Bailey et 
al. (15) confirmed that stress increases the capacity of macrophages to kill microbes. Bailey et al. 
(17) also reports that exposure to chronic stress, in mice, leads to an overgrowth of pathogenic 
strains of bacteria. However, Allen et al. (18) described that antibiotic treatment reduced splenic 
macrophage microbicidal activity. Further, mice that lack microbiota are deficient in killing 
target pathogens (16).Commensal microbes that are anti-inflammatory can reduce colon 
inflammatory responses (e.g., Lactobacilli) (19, 20), but these can be reduced by stress (14) thus 
priming the environment for mucosal inflammation. Bacteria of the genus Lactobacillus have 
been shown to impact the inflammatory status of colitis in humans and animals (21).  
Therefore, we investigated whether exercise training alters the population of lactobacilli in 
the colon as a potential contributing factor for the exacerbated DSS response witnessed in 
exercise trained mice. For this experiment, 8-10 week old C57Bl/6J male mice were exercise 
trained for 30 sessions (FTR and VWR) and 24 hours after their last exercise bout were 
euthanized. Colon tissue was harvested and the microbiota were collected by scraping the 
mucosal layer in the colon. We then performed Real Time-PCR to probe for total lactobacilli. If 
we discover a decrease of lactobacilli in mucosal scrapings, then we will conclude that treadmill 
exercise may be a stressor for the luminal microbiota and therefore alters the ratio of protective 
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(Lactobacillus) vs. total bacterial content. If we find no change or increases in lactobacilli in 
trained animals, then this would not support our hypothesis. An alternative explanation could be 
that DSS alone may be culpable, as DSS has been shown to alter the protein expression in E. coli 
that may make them more pathogenic (22).  
Our preliminary data demonstrate exacerbated mortality in response to DSS in FTR mice. To 
investigate a potential mechanism responsible for their death, we will examine the mesenteric 
lymph nodes for the presence of bacterial content (bacterial translocation). It is understood that 
stress increases the translocation of bacteria into lymphoid organs (23) and DSS interrupts the 
intestinal epithelial cell membrane. We hypothesize that treadmill training will result in greater 
bacterial translocation, systemic inflammation resulting in an outcome of mortality. This would 
support septicemia as a potential mechanism for the deaths witnessed.  
1.2.3 Specific Aim 3 
Is voluntary wheel running (VWR) similar to treadmill exercise training in inducing 
exacerbated colon inflammation and symptomology associated with DSS-induced colitis?  
One could argue that forced treadmill exercise may be perceived as an uncontrollable stressor 
for mice. Indeed, other stressors such as social defeat and overcrowding stress in mice lead to 
exacerbated inflammation and symptomology in the DSS colitis model (24, 25). The thymus 
gland is sensitive to stress, both immunological and restraint, resulting in a reduction in size and 
T-cell production (26). Reber et al. (24) reported that chronic psychological stress before the 
induction of colitis by DSS resulted in slower body weight gain, thymus atrophy, adrenal 
hypertrophy, impaired recovery, and increased severity of inflammation all without any 
differences in corticosterone concentrations. Thymic involution has been correlated with the 
7 
 
severity of DSS-induced colitis (27) but not all psychological stressors have been associated with 
increased severity of DSS-induced colitis. Larsson et al. (28) reported that repeated exposure to 
water avoidance stress doesn’t exacerbate DSS-induced colon sensitivity and function. Further, 
Moraska et al. (29) reported that forced treadmill running results in beneficial training 
adaptations but also physiologic characteristics of chronic stress (adrenal hypertrophy, thymic 
involution) in Sprague-Dawley rats. There are no data substantiating this effect in treadmill 
trained C57B/6 mice.  
Therefore, to determine whether the potential stressful nature of forced treadmill running 
(FTR) is responsible for the detrimental effects we have seen in our experiments, we performed 
an experiment using 30 days of voluntary wheel running (VWR); which is a non-stressful 
alternative to FTR. As we initially hypothesized that it is the running and not the uncontrolled 
nature of the treadmill exposure that is causing the exacerbated responses to DSS, we expected 
the same exacerbated inflammatory response in VWR mice as we have witnessed in FTR mice at 
disease peak (Day 8). If this result is observed, then we will conclude that it is the running, and 
not the stress of forced running, that is responsible for our findings. If VWR does not result in 
similar findings (e.g. no or beneficial effect) then we will conclude that FTR is stressful in this 
model and that the stressful uncontrollable environment caused the exacerbated response to DSS. 
Further, we will investigate the effects VWR has on macrophage presence after training in colon 
sections (Aim 1), microbiome characteristics (Aim 2), and the effects of both exercise paradigms 
on bacterial translocation, adrenal, and thymus characteristics. We believe these factors are of 
prime importance in the regulation of colon inflammation in our model. 
1.3 Summary 
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This research aims to examine potential mechanisms of moderate treadmill exercise 
training (FTR) on exacerbated colon pathophysiology in dextran sodium sulfate (DSS)-induced 
and to examine the effects of voluntary wheel training (VWR) (a non-stressful alternative to 
treadmill training) at disease peak in DSS-induced colitis. Our data demonstrates that FTR, prior 
to the induction of acute colitis, exacerbates colon inflammation and results imply this occurs 
from exercise induced modulation of chemokine expression (↑CCL6). Thus it is important to 
understand this phenomenon and determine how exercise training modifies disease activity in the 
colon through the characterization of immune cell shifts as a result of training (Aim 1) and 
microbiome characteristics (Aim 2) after FTR and during colitis. Further, we will explore 
whether FTR is a chronic stressor and responsible for exaggerated inflammation by investigating 
if VWR elicits the same effect (Aim 3). Importantly, and directly related to those who exercise 
regularly, these studies will also aid in identifying potential underlying mechanisms involved in 
exercise training initiation of exacerbated colon inflammation in athletes and those genetically 
susceptible to ulcerative colitis.  
Figure 1: Study Design and Hypothesis 
 
C57Bl/6 mice 
Exercise (FTR & VWR) 
30 sessions (FTR) or 30 days 
(VWR) 
FTR/H2O: ↑ macrophage 
cell presence & ↓ 
Lactobacilli compared to 
Sed/H2O  
VWR/H2O: ↔ in macrophage 
presence & ↑  Lactobacilli 
compared to Sed/H2O.  
VWR/DSS: ↓ Inflammation 
compared to FTR/DSS 
Sedentary 
Sed/H2O: ↓ macrophage cells and 
↑ Lactobacilli compared to FTR/H2O 
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CHAPTER 2  
LITERATURE REVIEW
1
 
2.1 Inflammatory Bowel Disease 
2.1.1 Epidemiology of the disease, prevalence, incidence, cost to society 
Inflammatory bowel disease (IBD: Crohn’s Disease & Ulcerative Colitis) has become a 
serious public health concern with 1 in every 1000 persons afflicted (30).  It is estimated that 
over 1.5 million people in the United States (US) alone suffer from this condition along with 
approximately 2.2 million in Europe (31), significantly reducing their physical functioning and 
quality of life (QoL). (32) Ulcerative colitis (UC) can affect all age groups, although there are 
peaks at ages 15 - 30 and then again from 50 – 70. Geographical studies on the prevalence of 
IBD’s in the US have shown a wide distribution of incidence among age ranges and throughout 
the country (33) while there seems to be no significant gender differences (34).  
Symptoms of UC can be very debilitating and disease activity fluctuates. Initial symptoms 
usually present as large intestine diarrhea, often bloody, that is associated with intestinal 
cramping and severe urgency to have a bowel movement. In cases of severe blood loss, anemia is 
common. Nausea, loss of appetite and subsequent weight loss are common, as well as fatigue. 
Additionally, there may be other disorders that are secondary to colitis such as skin lesion, joint 
pain (arthritis), osteoporosis, eye inflammation, and liver disorders. Sadly, children who have 
UC may fail to grow and develop properly. Local (colon) and systemic dysregulated immune 
actions are proposed to be liable for the conditions above. For example, Agrawal et al. (35) 
discuss the molecular pathways of bone loss, a leading cause of morbidity in IBD patients, 
                                                          
1
 This chapter contains 2 figures that have created by committee members (Figure 2. Dr. Rex Gaskins PhD; Figure 3. 
Dr. Matt Wallig PhD). Permission has been granted to use these figures in this manner.  
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mediated by inflammation in IBD. These processes, along with altered absorption of nutrients, 
are implicated to be causative for the waning physical development observed in pediatric IBD 
sufferers (36).  
Health disparities do exist among affected persons. Medically-insured patients are more 
likely to receive a positive diagnosis of IBD in comparison to those on Medicaid, which may 
speak to the socioeconomic factors in diagnosis and treatment of these disease processes. While 
incidence and prevalence rates are rising around the world, health care costs associated with 
IBD’s are also rising. Therapeutic drug therapies to manage disease activity are very expensive 
while cost-effectiveness ratio estimates from some studies have not been helpful in determining 
the average cost of treatment strategies (37, 38). For example, the anti-inflammatory (anti-TNF-
α) drug Remicade (Infliximab), also used to treat rheumatoid arthritis, can cost patients anywhere 
from $8,000-$12,000 for treatment during a disease flair. Flairs of UC are sporadic but may 
occur multiple times per year. Further, antibiotics, steroids, and pain relievers are common 
staples of treatment that amplify costs and are associated with significant adverse effects that 
affect quality of life (39).  
According to American College of Surgeons 96th Annual Clinical Congress in 2010, the 
treatment of chronic ulcerative colitis alone costs $2.1 billion annually in the United States. 
Although there are several drugs to treat the disease, up to 40 percent of patients require surgery 
because of failure of medical therapy (40). A population based study in 2009 estimated that the 
surgical cost incurred from surgery and recovery ranged from $39,309 to $50,530 (41). Surgery 
was concluded to reduce the cost when compared to medical therapy by $12,000 over a two year 
period, but there have been no long-term recover care studies to date that have followed patient 
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care costs longer than 2 years. Complications include “Pouchitis”, as a result of the restorative 
proctocolectomy surgical procedure, which is an inflammation of the pouch that occurs in about 
30 percent of patients. Also common is bowel obstruction which may develop due to adhesions 
or scar tissue from the surgery with one-third of those patients requiring additional surgery to 
remove the blockage. About eight to ten percent of patients will have pouch failure, which 
requires removal of the pouch and conversion to a permanent ileostomy (40). These surgical 
procedures are considered optional to unsuccessful therapeutic drug management of disease 
activity and are subject to not be covered by medical insurance in many cases. This adds to the 
burden of medical treatment options for effective disease management. With this, UC is also 
associated with an increased risk of colitis-associated cancer (CAC) (42). 
2.1.2 Pathophysiology of the disease 
Ulcerative colitis is a chronic inflammatory disease of the large intestine with periods of 
remissions and relapses of acute colitis. The disease is marked by inflammation consisting of 
polymorphonuclear infiltrates (39). Ulcerations expose the colon crypts and lining to the extent 
where they bleed and produce abscesses within the tissue facing the lumen. Disease activity is 
usually restricted to the mucosa. Intestinal inflammation causes frequent emptying of the 
intestine, cramping abdominal pain, and bloody diarrhea (39). 
Although IBD’s have been studied extensively, researchers do not yet know the origin of 
UC. Studies indicate that the inflammation involves a complex interaction of genetic factors, the 
immune system, and environmental factors (30, 43). Environmental factors may be the direct 
cause of the inflammation, or they may stimulate the body's defenses to produce an inflammatory 
response that continues without control and cannot be calmed at the appropriate time. As a result, 
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inflammation damages the intestine and causes the symptoms of UC. Dysregulation in immune 
activity involving both the innate (e.g., dendritic cells, neutrophils) and the adaptive immune 
systems (e.g., effector T-cells, regulatory T-cells) may follow or precede the macroscopic lesions 
(44). Thus the objective of medical therapy is to help the patient regulate their immune system 
better. 
The complications of UC are generally categorized as either local or systemic. Local 
refers to complications involving the intestinal tract itself and systemic refers to the involvement 
of other organs or complications that affect the patient as a whole beyond the intestine. 
According to PubMed Health, systemic complications, including fever, weakness, and loss of 
appetite are a reflection of the inflammation in the colon (45). Further, the correlation between 
disease severity and co-morbid lifetime psychiatric disorders have been well recognized. These 
conditions are primarily depression and anxiety (46, 47). Due to the unpredictable course of 
ulcerative colitis, it often makes it perplexing for physicians to assess whether a particular course 
of treatment will be effective.   
2.1.3 Current treatments for the disease and their efficacy 
Presently, there is no medical cure for UC and therapies consist of suppressing the 
chronic intestinal inflammation, inducing and maintaining remission of the disease to improve 
the patient’s quality of life. Controlling this persistent inflammation optimizes colon function 
and can prevent surgery and long-term complications such as colitis-associated cancer.  
Several medications have proven effective in controlling disease activity. At present, 
there are five major classes of medication are used to treat UC. Aminosalicylates (5-ASA) are a 
class of anti-inflammatory drugs that are typically used to treat mild to moderate episodes and 
13 
 
are effective in resolving inflammation and greatly diminishing symptoms such as diarrhea, 
rectal bleeding, and abdominal cramping. Corticosteroids, such as Prednisone and 
methylprednisolone, nonspecifically suppress the immune system and are used to treat moderate 
to severely active colitis. These drugs have significant short and long-term side effects and are 
not prescribed to be used as a maintenance medication. Immune modifiers are used to help 
decrease corticosteroid dosage and dependency. They also accommodate maintenance of 
remission in colitis patients who are non-responders to standard medication therapy (5-ASA’s). 
However, these medications can take as long as three months before their beneficial effects begin 
to work. Antibiotics such as metronidazole, ampicillin, and ciprofloxacin are used in 
combination with other drugs to control bacterial pathogenesis in the colon. Biologic therapies, 
such as Infliximab (anti-TNF-α) infusions, are the newest class of drugs used for people 
suffering from moderate to severe colitis. These compounds are created from antibodies that bind 
with certain molecules to block the action of immune modulators (cytokines). The intestinal 
inflammation of UC is a result of dysregulation of many pathways and because biologic drugs 
target specific pathways, they may only help reduce some of the inflammatory processes and 
side effects. Many of these therapeutics are also used for managing other inflammatory disease 
processes associated with colitis, such as Infliximab for arthritis. Although Infliximab is a potent 
anti-TNF-α drug, its effectiveness in reducing some symptoms of colitis is not conclusive (48). 
As the etiology of UC varies, treatment options must also be diverse and biological therapeutics 
that target signaling pathways of effector cells are important (49). Newer classes of compounds 
are becoming available but side effects of long-term use have not been characterized (50).  
Due to the chronic nature of this disease, repeated treatment with these drugs are often 
necessary to control symptoms and maintain remission. Long-term use of corticosteroids, 
14 
 
immune modifiers, antibiotics, and biological therapies can increase the risk of osteoporosis, 
mask infection, increase susceptibility to infection, and propagate resistance leading to other 
acute or chronic disease processes (51, 52). For example, glucocorticoids are powerful anti-
inflammatory mediators, but it is known that glucocorticoid metabolism is already altered with 
an active bout of colitis (53). Thus, corticosteroid therapy is potentially redundant and may pose 
long-term immunomodulatory effects. With this, there is a demand for alternate methods of 
reducing inflammation during this disease process.  
2.1.4 Ulcerative colitis and its link to other chronic inflammatory diseases 
Some UC patients, including adolescents, have been diagnosed with arthritis, skin 
conditions, ocular inflammation, liver and kidney disorders, bone loss, and psychological 
disorders. (54-57) Arthritis is the most common complication while joint, eye, and skin 
complications often occur together. Since abnormal gut inflammatory processes cross the 
boundary of the intestine in UC, these further conditions may be a direct result of gut 
inflammation (54, 55), or side effects of therapies (50). Systemic manifestations may dominate 
intestinal symptoms that may affect diagnosis. It is reported that osteoporosis is a leading cause 
of morbidity in patients with IBD. Bone loss is an early systemic process that often occurs even 
before clinical colitis manifests (35). Further, patients who suffer with UC have a higher risk for 
the development of colon cancer (2). With this, it is important to elucidate the effects of exercise 
on modulation of gut immune function. The mechanism behind disease activity improvements 
with exercise in IBD and CAC are currently unknown. 
Current research focuses largely on microbial and antigen responses (43, 58), biological 
therapeutics (50), identification of biomarkers of colon cancer in humans (59, 60) and animal 
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models, epidemiologic studies (61), and assessment of therapies’ effect on QoL. The trigger for 
developing colitis varies among individuals. It is not clear whether the initiation of UC is 
external (e.g., bacterial or viral) or internal (e.g., augmented gut immune tolerance or genetic). 
By studying microbes and the body's response to them, researchers may be able to determine 
which environmental triggers are involved providing essential information on the development 
of intestinal inflammatory disorders (62-64).  
In summation, controlling wayward inflammatory processes is the focus of research for 
clinical treatment of the disease. Interestingly, an alternative to current treatment protocols is the 
implementation of moderate exercise in the reduction of inflammation (6, 56, 65), even though 
the mechanism behind its gut altering immune function capabilities have not been explicated.   
2.2 The Intestinal Epithelium 
The intestinal tract is lined by epithelial cells that are shielded by a mucosal layer. This 
mucosal surface allows for protection of the tissue from bacteria and other potentially harmful 
substances in the lumen (Figure 2). Intestinal epithelial cells (IEC) facilitate nutrient exchange 
and participate in gut protection and intestinal tolerance. Some IEC have highly specialized 
functions such as secreting mucous (goblet cells) and antimicrobial peptides (Paneth cells) to 
control bacterial colonization (32). Interestingly, IEC participate in tolerance through decreased 
expression of TLR’s (TLR4) and other elements necessary for recognizing bacterial antigens at 
its luminal surface. However, these same cells have augmented expression of TLR’s (TLR5) on 
their basolateral side to identify microbes that have breached the protective layer (66). Thus, IEC 
function and dysregulation participate in the pathophysiology of the disease. 
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The intestinal immune system has to effectively discriminate among beneficial 
commensal bacteria, harmless agents, and pathogenic microbes. The function of gut immune 
cells is to maintain the balance between immune responsiveness and tolerance. When this 
balance is perturbed, inflammatory bowel diseases can develop (67, 68). 
2.2.1 The intestinal immune system 
The intestine has highly specialized compartments and cells that facilitate its immune 
surveillance including Peyer’s patches (PP), mesenteric lymph nodes (MLN), lamina propria 
(LP), and IEC. PP are lymphoid organs located in the submucosal space and extend upward to 
the IEC layer. Near these organs are specialized epithelial cells called microfold (M cells) cells 
whose function is to capture antigens and transport them to dendritic cells (DC) that are 
associated with the PP’s for processing (69). MLN, the largest lymph nodes in the body, are 
highly organized draining lymphoid tissues connected to PP, the LP, and to the peripheral 
immune system. Migration of immune cells from the gut into the periphery happens through 
Figure 2. Colon epithelial layer and associated cells 
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these structures. The lamina propria consists of connective tissues underlying the gut epithelium. 
T cells, B cells, monocytes (DC, macrophages) and granulocytes (neutrophils) are the major cell 
types present here (66, 70) with DC, T cells (Th17), and neutrophils being the first responders to 
an acute colitis insult.   
Active UC is hallmarked by an immense infiltration of innate immune cells into the 
lamina propria. The innate immune cells provide the initial and rapid response to microbes. 
Increased numbers and activation of these cells in the intestinal mucosa elevate local levels of 
pro-inflammatory cytokines tumor necrosis factor α (TNF-α), interleukin-1β (IL-1 β), and 
interleukin-6 (IL-6). Cytokines are important regulators of immune cell trafficking and have 
emerged as essential immune molecules in the pathogenesis of IBD’s (71). UC is characterized 
by increased pro-inflammatory cytokine expression in the colon that causes hypercontractility of 
intestinal smooth muscle leading to debilitating cramping and increasing bowel motility (72). IL-
6 neutralization has been shown to improve gut function and lessen the severity of symptoms. 
IL-6, IL-1β and TNF-α can cause activation of submucosal secretory neurons thereby acting as 
neuromodulatory factors that can directly influence such gut functions as motility, absorption, 
secretion and blood flow (47, 54). Breakdown of the mucosal barrier by IL-6 and other pro-
inflammatory cytokines may provide access for foreign antigens through its mechanistic pathway 
of causing proteasomal degradation of tight junction proteins (73). IL-17 and IL- 23 play crucial 
roles in intestinal protection and homeostasis. IL-23, produced by activated DC in the colon, is 
expressed in gut mucosa and tends to orchestrate T cell independent pathways of intestinal 
inflammation as well as T cell dependent pathways mediated by cytokines produced by Th1 and 
Th17 cells. Th17 cells have specific functions in host defense against infection by recruiting 
neutrophils and macrophages to infected tissues (74). Therefore, the intestine provides a highly 
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sensitive indication of immune dysregulatory disorders, making it useful to study IBD disease 
models to detect key regulators in the balance of the mucosal immune system (75). 
Numerous studies indicate that IL-23 plays a major role in the pathogenesis of 
experimental colitis (76-80). Dendritic cells are a dominant cell type in the lamina propria and 
major producers of IL-23 (81) that propagates the activation and survival of Th17 cells and their 
production of IL-17 resulting in the recruitment and activation of effector immune cells 
(neutrophils) in some inflammatory diseases including colitis (82-85). Blocking IL-23 action has 
been shown to reduce the inflammatory response in IBD and has become a popular 
pharmaceutical drug target (77). IL-23 production has been exposed as a suppressor of regulatory 
T cell function in colitis (86) and may be important in our model of exercise induced 
exacerbation of ulcerative colitis. As IL-23 is important in directing the innate immune function 
(87), it may suppress the number of active regulatory T cells (Tregs), as suggested by Izcue et al. 
(86), thus propagating sustained inflammation and further warranting the investigation of 
dendritic cell population in the colon.  
Th17 cells are critical for defenses against pathogens and excessive entry of luminal 
microorganisms, but expansion and over activity of these cells relative to the regulatory CD4+ T 
cells (Tregs) can lead to persistent intestinal inflammation (32, 43). Tregs account for about 10% 
of the CD4
+
 cell population while possessing the ability to suppress proliferation of CD4
+
 and 
CD8
+
 effector cells. The importance of these cells in overall immune tolerance has been 
characterized (66). Deletion of Tregs, by antibody administration, leads to the development of 
auto-inflammatory lesions in several organs, including the intestine (88). They induce their 
effects by secreting IL-10 (89) which attenuates the aggressiveness of innate and adaptive 
immune cell types. Importantly, Treg production of IL-10 is needed to attenuate Th17 driven 
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inflammation (90). Indeed, IL-10 knock-out mice develop colitis (91) and IL-10 abnormalities in 
humans are associated with the development of IBD (92). These cells are also important in 
maintaining colon homeostasis and intestinal tolerance to commensal microbes (81). In patients 
suffering with UC, Tregs are reduced systemically and in the gut (93). Interestingly, Tregs have 
been shown to be beneficially responsive to exercise training in other tissues where inflammation 
is induced (94) and data suggests that Tregs are effective in preventing colitis by inhibiting the 
accretion of effector cells into the colon (95). Specifically, aerobic training is known to be 
beneficial in protecting intestinal lymphocyte presence and activity in the colon (96) after an 
acute exercise stressor. Since Tregs are a major manufacturer of the potent cytokine IL-10 in the 
colon, this suggests that training may modulate Treg function. Currently, it is not known how 
Treg presence in the colon participates in the exercise induced exaggeration of inflammation in 
DSS-induced colitis. 
2.2.2 Chemokines 
Numerous data indicate that that intestinal chemokine expression is non-selectively up-
regulated in IBD and correlates with disease activity. Chemokine’s are small proteins that direct 
immune cell trafficking under homeostatic and inflammatory conditions in the gut. They also 
have antibacterial properties. Blocking chemokine action has been shown to alter CD8+ T cell 
homeostasis in the epithelium and lamina propria (97). CC chemokine’s are implicated for 
lymphocyte and dendritic cell recruitment. CCL6 in the crypt regions of the colon function as 
antibacterial peptides that have been shown to bind to intestinal microbiota and stimulate the 
innate immune response (11, 12) and are the most abundant chemokine expressed by colonic 
epithelial cells and is also expressed by macrophages. It works by increasing dendritic cell 
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recruitment and activation. Further, human CCL14 and CCL15 expression is elevated in patients 
diagnosed with ulcerative colitis (12).We observed an increase in Ccl6 expression of in the colon 
after exercise training. Exercise has been shown to be anti-inflammatory and we believe exercise 
training could bolster immune-surveillance potential in the colon, by increasing chemokine 
expression and antibacterial function, and improving immunity during homeostasis. 
Unfortunately, this adaptation may be detrimental in individuals predisposed to ulcerative colitis 
causing an exaggerated inflammatory response thus increasing disease activity.  
2.2.3 The Intestinal Microbiome and Stress 
The human microbiome consists of approximately 10
13
 to 10
14
 microbial cells, which 
outnumber human host cells roughly 10 to 1 (98). These microbes have niches across the entire 
body (skin, reproductive organs, and digestive organs). The intestinal microbiota is a necessary 
part of the human body. These microbes have enriched metabolic processing that processes 
essential nutrients and have critical interactions with immune cells that are crucial for the 
development and regulation the immune system (99, 100). Intestinal dysbiosis, or an unbalanced 
microbiota that is characterized by reductions in the beneficial colonies of bacteria, is suggested 
to be responsible for inflammatory bowel diseases (101).  
Investigating the role of the intestinal microbiota and its relationship to regulating the 
activity of the intestinal immune system is of great clinical importance (102, 103). Sartor and 
Muehlbauer (102) explain that IBD (Crohn’s disease, Ulcerative colitis) are a result of 
dysregulated immune responses to distinct antigens from the luminal microbiome. Malfunctions 
in immune regulation have been linked to 1) leaky IEC barrier, where tight junctions or 
colonization of bacteria stimulate IEC to reduce barrier function; 2) mucosal epithelial layer has 
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an abnormal expression of TLR on its surface that is responsible for over activation of the pro-
inflammatory immune response toward commensal bacteria, which they are normally tolerant of; 
3) inappropriate activation of DC (increased expression of TLR) toward commensal bacteria and 
dysregulated tolerance; 4) antigen processing cells (M cells, DC, macrophages) become potent 
activators of T cells and drive Th1 and Th2 mediated inflammation; 5) inability to deactivate 
over-reactive or auto-reactive immune cells. Additional reasons include genetic polymorphisms 
resulting in reduced microbial killing capacity and innate or adaptive immune responses toward 
multiple antigen exposure in the gut (microbial or nutritional) (104, 105). Even though the 
etiology of UC is still unknown, chronic inflammatory responses toward luminal antigens in the 
colon are proposed to be the driving force behind this disease. Therefore, any alterations in the 
commensal bacterial community will affect gut homeostasis and pathogenic responses of the 
intestinal immune system.  
Stress has been associated with activation and re-activation of colitis in humans (106) and 
animal models (107, 108) and the microbiome is also reactive to stress (14, 109), In fact, Bailey 
et al. (13) reported that commensal bacteria are altered by social stress which impacts intestinal 
immune function. Stress also increases the potential of systemic infection because it is associated 
with increased translocation of microbiota into lymphoid organs (23). Hence, any perceived 
stress, psychological or physiological, requires investigation into their potential effect on 
microbiome characteristics in the context of this disease and experimental models. In review, 
Bailey (14) has provided valuable information, from his own work and others, about consistent 
shifts witnessed in certain bacteria populations that are very sensitive to stressors (e.g., 
Lactobacillus). Certainly, some bacteria are detrimental, some are neutral, while others are 
protective. Bacteria of the genus Lactobacillus are important in the gut and are protective. They 
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can form a barrier between the epithelial cell layer and the lumen to help protect against 
colonization of pathogenic bacterial strains. They also are known to generate hydrogen peroxides 
that are protective against other gram-negative and gram-positive bacteria. Further, feeding 
probiotic Lactobacillus cultures to transgenic models of spontaneous colitis has proven to be 
protective against colitis (21).  Our preliminary results show that treadmill training increases the 
expression of Ccl6, a chemokine that has direct antimicrobial function. Therefore, this adaptation 
may alter the balance of the microbial species. It is not known if exercise training and DSS affect 
lactobacillus populations in the intestine. However, it is known that DSS administration does 
alter protein expression in E. coli strains of the microbiota (22). Therefore, it is also important to 
understand if these treatments (exercise training or DSS) affect the presence of lactobacilli in the 
colon.  
2.3 Exercise in Ulcerative Colitis 
Overall, physical activity (PA) decreases all-cause morbidity by increasing 
cardiovascular health (improving fitness and functional capacity) (110, 111), metabolic health 
(112), contributing to weight loss and maintenance of healthy weight, improving musculoskeletal 
health (reducing the risk of osteoporosis), and improving mental health (113). The effects of 
moderate exercise have been categorized as anti-inflammatory by reducing systemic biomarkers 
of inflammation (C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor-α) (4) and 
modulating the immune response in animals (114, 115) and humans (116). The positive effects 
of increased physical activity have led to the implementation of exercise in the treatment and 
prevention of diseases believed to be sustained and exacerbated by inflammation (117-120).  
IBD patients have been reported to use physical activity as an adjunctive therapy regime 
although the effectiveness of exercise on disease activity has not been well characterized in the 
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literature. More importantly, the mechanisms explaining the effects of exercise are not fully 
understood.  Packer et al. (121) found four studies reporting positive results of physical activity 
on quality of life and attenuation of symptoms and disease activity but no evidence for its effects 
on immune outcomes. However, it is clear that exercise does not lead to relapse or exacerbation 
of disease activity in humans (118). In animals, evidence from our laboratory has demonstrated 
that moderate intensity exercise training skews the Th1/Th2 balance towards anti-inflammatory 
Th2 response, characterized by a reduction of  pro-inflammatory cytokines (TNF- α, IL-1, IFN-γ) 
and an elevation of anti-inflammatory cytokines (IL-10, IL-4) (114). Hoffman-Goetz et al. 
evaluated the intestinal lymphocyte cytokine response to an intense acute bout of exercise, and 
found that anti-inflammatory and pleiotropic cytokines (1L-10 and IL-6, respectively) were 
increased, while pro-inflammatory cytokines (TNF-α) were significantly decreased in exercise 
trained animals (10, 122). These studies promote the concept that exercise training is anti-
inflammatory and confirm the need to characterize the effects of moderate exercise during 
intestinal inflammation.  
Interestingly, the therapeutic potential of exercise on immune cell and IEC function in 
UC patients is promising in a few aspects. Although knowledge is limited in understanding the 
role of Tregs in the pathogenesis of IBD, they have the ability to alter regulatory pathways that 
may be a critical avenue for achieving long term remission in patients (123). Exercise has the 
capability of improving Treg function in other chronic inflammatory states, such as asthma (94), 
and acute exercise has also been shown to increase T-lymphocyte suppressor cell function in 
healthy men (124). Moreover, Yeh et al. reported that 12 weeks of participation in a Tai Chi 
intervention in middle-aged individuals increases peripheral Tregs and in vitro production of 
anti-inflammatory cytokines (TGF-β & IL-10) (125). Thus, habitual exercise may potentially 
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enhance the inflammatory suppressive function of Tregs in the bowel, also reducing symptoms 
and improving QoL and disease activity outcomes in patients. Further, exercise has been shown 
to induce heat shock proteins that are protective (Hsp-70) against exacerbated inflammation 
through the modulation of NF-κB in the colon. (126)   
It is well established that exercise affects GI function. Acute or intense exercise may 
induce GI symptoms, which are fleeting and do not cause long term problems. Elite athletes 
often experience debilitating symptoms that include nausea, diarrhea, and GI bleeding related to 
bowel ischemia, mechanical or neuroendocrine factors associated with exercise intensity (127, 
128). This may be a protective mechanism to reduce end-organ damage by prompting the athlete 
to reduce exercise intensity or duration (118).  
2.3.1 Moderate Exercise, Exercise Training & Ulcerative Colitis 
Several studies have shown an association of low to moderate exercise and an 
improvement in the immune function (4, 129-131). Any therapy that can boost immune function 
has beneficial value in this population, especially if it is non-pharmacological, as many drugs 
have multiple side effects. This population has a need for randomized clinical trials to study the 
effectiveness of exercise in improving disease activity just as other chronic inflammatory 
conditions have (112, 132). The rationale for these types of studies is supported by animal 
studies that provide a mechanistic view into the exercise induced modulation of immune activity. 
Ulcerative colitis patients utilize exercise as an alternative avenue for management of disease 
activity and symptoms as research suggests physical activity may give them greater control over 
their IBD (118, 121). Disease activity is associated with increased utilization of alternative 
methods of treatment especially when conventional medical practices have failed (133).   
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Prospective studies on exercise and their impact on disease activity are lacking but some 
do exist. Most of the information available is on lifestyle choices and IBD activity accessed from 
questionnaires. Elsenbruch et al. (134) reported that mind-body intervention (including exercise 
and diet intervention) improved psychological health and  score on the Inflammatory Bowel 
Disease Questionnaire (IBDQ) suggesting improved quality of life. Unfortunately, this study 
reported no change in variables of immune function (modulation of circulating TNF-α or subsets 
of leukocytes) in the intervention group. It is important to note that these individuals had a lesser 
immune burden compared to those with greater disease activity, thus no change in inflammatory 
status. In a large study of individuals with IBD from 1991-1996, Cucino et al. (135) reported that 
mortality rates among persons with IBD are lower if they manual laborers when compared to 
those who worked indoors. This suggests that patients in remission or suffering from mild-
moderate disease activity can safely participate in moderate physical activity. Unfortunately, this 
conclusion is not because complete interventional studies have been carried out to examine the 
effectiveness of exercise in symptom improvement or reduction in inflammatory states in this 
population, but solely because the evidence for moderate physical activity has been validated as 
anti-inflammatory overall. For example, exercise induces the pleiotropic cytokine IL-6 which 
leads to induction of anti-inflammatory factors such as IL-1 receptor antagonist and IL-10 and 
inhibits the pro-inflammatory cytokine TNF-α and IL-1 (65) and potentially a direct benefit of 
exercise in sufferers of ulcerative colitis. 
In addition to the colon pathophysiology which occurs in UC, many patients report a 
reduced quality of life characterized by fatigue, sleep disturbance, inability to perform daily 
tasks, and a depressed emotional state (136).  Clinical depression is more prevalent in IBD 
patients compared to the general population (46). Evidence implicates the role of pro-
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inflammatory cytokines in the etiology of depression associated with chronic inflammatory 
diseases (137).  Elevated levels of circulating pro-inflammatory cytokines, particularly TNF-α, 
IL-1, and IFN-γ, cross the blood brain barrier, where they alter neurotransmitter synthesis and 
metabolism.  Clinical studies demonstrate that exercise (3) as well as cytokine specific anti-TNF-
α antibodies reduce depression and improve quality of life in IBD patients (48).   
2.4 Mouse Models of Intestinal Inflammation 
Dextran sodium sulfate (DSS) dissolved in drinking water induces an acute colitis 
characterized by bloody diarrhea, ulcerations and infiltration of immune cells. Although the 
mechanisms underlying DSS-induced damage to the colon remain unclear, hypotheses propose 
that it is directly toxic to intestinal epithelial cells, increases macrophage and neutrophil activity, 
and affects the integrity of the mucosal barrier by increasing permeability (138-141). In mice, 
this model closest resembles the pathology and histology of human UC and therefore is an ideal 
model to study the effects of exercise induced modulation of gut inflammation during an acute 
bout of colitis. Effects of DSS-induced colitis are shown below in Figure 3: (decreased goblet 
cells and crypt elongation secondary to necrosis, lumenal pus, activated lymphoid nodule, 
submucosal edema, neutrophil infiltrate and inflammation- pic referenced M. Wallig & S. Butler 
2009). 
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Figure 3. Histological assessment of DSS-Induced Colitis  (M. Wallig & S. Butler 2009) 
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CHAPTER 3 
METHODOLOGY 
3.1 Animals 
Eight to ten week old C57Bl/6J male mice were purchased from Jackson Laboratories 
(Bar Harbor, ME) and individually housed in cages with corncob bedding in an AALAC 
accredited specific pathogen-free (SPF) barrier facility. Animals were housed under a reverse 
light-dark cycle (lights on at 9 PM, lights off at 9 AM) in a low stress environment and given ad 
libitum access to sterile water (unless during the study) and autoclaved rodent chow. Mice were 
acclimated to the housing room for 1 week prior to any experiments. All corncob bedding and 
cages were sterilized before use and were changed weekly. Animal studies were conducted under 
the guidelines of the University of Illinois, Urbana-Champaign Animal Care and Use Committee 
and approved by the University of Illinois Urbana-Champaign IACUC (protocol 12075). 
3.2 Exercise Training Methodology 
3.2.1 Forced Treadmill running (FTR): Prior to training, C57Bl/6J male mice were 
randomized into four groups and matched on weight (Sedentary/H2O, FTR/H2O, Sedentary/DSS, 
and FTR/DSS). Mice were briefly introduced to the treadmill 1 week prior to starting training 
with 3 nonconsecutive days of running for 10-25 minutes per session. Thereafter, animals 
performed 6 weeks (5 days/week; 30 days) of moderate forced treadmill running (8-12 m/min; 
5% grade) for 40 minutes per day prior to 2% Dextran Sodium Sulfate (DSS) treatment for the 
induction of colitis. Mice did not run during or after DSS treatment to minimize distress. We 
monitored body weight, fecal consistency, food, and fluid intake until tissues are harvested at 
Days 6, 8 (disease peak), and 12 (recovery). All mice will be handled similarly and housed in 
close proximity to the treadmill during training.  
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3.2.2 Voluntary wheel running (VWR): Prior to training, C57Bl/6J male mice were 
randomized into four groups and matched by body weight (Sedentary/H2O, VWR/H2O, 
Sedentary/DSS, and VWR/DSS).  Mice were individually housed in a cage (48 L  26 W  15 H 
cm) that contained a wireless low-profile running wheel (circumference 37.82 cm)(Med 
Associates, St. Albans, Vermont) where wheel revolutions were relayed via telemetry to a 
computer in the facility. Sedentary mice were individually housed in standard shoebox cages (30 
L  19 W  12 H cm). Mice were allowed unlimited access to running wheels for 4 weeks (~30 
days) for training. In order to compare treadmill training (FTR) with VWR animals, mice were 
allowed access to wheels for 30 days; the same number of treadmill training days. Upon inducing 
colitis, wheels were locked so mice were not able to voluntarily exercise. Ulcerative colitis was 
induced by 2% dextran sodium sulfate (DSS) treatment in exercised or sedentary C57Bl/6 mice 
after the 4 weeks. We monitored symptomology (body weight, fecal consistency, food, and fluid 
intake) until tissues are harvested at Day 8 (disease peak).  
3.3 Dextran Sodium Sulfate administration 
Regular drinking water was replaced by 2% DSS in sterile water (w/v, MP Biochemical 
36,000-50,000 MW) for a period of 5 days after completion of the exercise intervention period. 
DSS was replaced with sterile water after Day 5 until euthanization. The DSS solution was 
monitored daily, refilled appropriately and replaced on Day 3.  
3.3.1 Morbidity. Daily measurements of body weight and food and fluid intake were 
made during and after DSS administration. In addition, mouse feces were evaluated in an 
observer blinded manner for consistency/diarrhea (e.g. formed pellet vs. semi-formed/soft) and 
were tested daily for the presence of blood (Hemoccult®) when appropriate (severe diarrhea). 
Lastly, we assessed the physical activity behavior (e.g. 1 = ‘normal, 2 = ‘slight reduction’, 3 = 
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‘limited’, 4 = ‘immobile’) in the home cage and response to capture (e.g. 1 = ‘normal evasion’, 2 
= ‘some evasion’, 3 = ‘no evasion’) as indicators of sickness behavior in a blinded manner. 
3.4 Tissue Analysis 
3.4.1 Tissue Collection: Mice were euthanized by CO2 asphyxiation and cervical 
dislocation. The colon was removed (distal to the caecum to the anus) and colon length assessed 
using a digital caliper to the nearest millimeter (Tresna). The colon was separated into proximal 
and distal ends. A 2 cm piece cut from the top portion of the distal half and was fixed in 10% 
buffered formalin solution for 12 hours, rinsed with sterile water, then stored in 70% ethanol 
until being paraffin embedded and sectioned (3µm) for immunohistochemical (IHC) analysis. 
The proximal end was utilized for mucosal scraping and harvesting of intestinal microbiota. To 
harvest the mucosal layer, the proximal colon was cut longitudinally, feces removed, and the 
mucosal layer was gently scraped with a round cover slide at a 45 degree angle. The scrapings 
were then placed into a screwtop cryovial and frozen in liquid nitrogen until isolation of bacterial 
DNA and analysis, by quantitative real time polymerase chain reaction (Real Time-PCR), of 
total Lactobacillus bacteria content. The distal colon was snap frozen in liquid nitrogen and 
stored at -80⁰C until analysis of immune markers by quantitative reverse transcription 
polymerase chain reaction (qRT-PCR). Mesenteric lymph nodes were harvested and snap frozen 
in liquid nitrogen until analysis of bacterial translocation to the lymph nodes by Real Time-PCR. 
3.4.2 Gastrocnemius Citrate Synthase (CS) Activity: Right gastrocnemius (gastroc) was 
isolated and the soleus removed. Muscles were frozen by dry ice and immediately stored at -
80⁰C until assayed for citrate synthase enzyme activity using a protocol adopted from P.A. Srere. 
(142) To briefly summarize, muscle was homogenized in phosphate buffered saline (pH 7.4) 
with 5µl protease inhibitor (Sigma-Aldrich). Aliquots underwent a freeze thaw process (3 times) 
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to break mitochondrial membranes. Protein content was determined by Bradford assay. Citrate 
synthase assays were then performed in a 96 well plate in duplicate. Data is reported as µmol CS 
activity/g/min. (Data represented in APPENDIX, Figure 20) 
3.4.3 Immunohistochemistry (IHC): IHC is a process that allows for the detection of 
specific proteins expressed on certain cell types, their presence and location in intact tissue 
sections. The tissue was sectioned at 3 μm and was stained for a cell specific marker for 
macrophages (F4/80). The protocol for IHC is as follows. Slides were deparaffinized in a series 
of xylene and ethanol washes (3x in Xylene for 2 minutes each, 2x 100% ETOH, 2x 95% ETOH 
for 2 minutes each, 2x 70% ETOH for 2 minutes each then washed in PBS pH 7.0). Slides were 
then placed in 3% hydrogen peroxide in water for 15 minutes, rinsed for 5 minutes in wash 
buffer (PBS, pH 7.0). Samples were then treated with heat (35-40⁰C) in citrate buffer (pH 6.0) 
for antigen retrieval. Slides were then rinsed, incubated with avidin and biotin blocks for 15 min, 
and rinsed in wash buffer again before the addition of the primary antibody (F4/80 rat 
monoclonal anti-mouse; Abcam #ab6640) for 30 minutes. After a brief wash, slides were then 
incubated with a secondary antibody (Rabbit polyclonal to Rat IgG (Biotin); Abcam #ab6733) 
for 20 minutes. Following another brief wash, streptavidin HRP (Abcam #ab7403) was added for 
15 min then rinsed. DAB was applied for 5 minutes, rinsed in wash buffer, then counterstained 
with Mayer’s Hematoxylin (Sigma-Aldrich) for 1 minute. Slides were then dehydrated, in a 
series of 100% ethanol and xylene rinses, and a cover slip was mounted. The cross sectional area 
of each slide was calculated and a blinded observer counted F4/80+ cells. Data is expresses as 
number of macrophages per cross sectional area and was analyzed using analysis of variance 
(ANOVA) (see Methods 3.5).  
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3.4.4 Analysis of Inflammatory Gene Expression: Quantitative Reverse Transcriptase 
Polymerase Chain Reaction (qRT-PCR) was used to determine inflammatory gene expression in 
colon tissue samples. Approximately 30 mg of each colon sample was homogenized using a 
tissue homogenizer (PRO Scientific PRO-250 rotary). RNA was extracted using the Applied 
Bioscience protocol (Applied Bioscience, Carlsbad, CA) and stored at -80C. Later, the reverse 
transcriptase reaction was performed using commercial first strand kits (Applied Biosciences, 
CA) and random hexamer primers, as described in the manufacture’s protocol. The RNA sample 
concentrations and purities are analyzed spectrophotometrically. Finally, the following genes 
were analyzed using a qRT-PCR machine (7900HT Fast Real-Time PCR system and SDS 
Enterprise Database): Pro-inflammatory cytokines (IL-6, TNF-α, IL-1β, IL-23, and IL-17A), the 
anti-inflammatory cytokine (IL-10), and the chemokines (CCL6 and CXCL1) were analyzed. 
(Applied Biosciences primers used: IL-1β, Mm00434228_m1; TNF-α, Mm00443258_m1; IL-6, 
Mm00446190_m1; IL-23, Mm00518984_m1; IL-17A, Mm00439618_m1; IL-10, 
Mm00439616_m1; CCL6, Mn01302419_m1; CXCL1, Mm04207460_m1; and glyceraldehyde 
3-phosphate dehydrogenase, Mm999999_g1). To perform the PCR reactions, Taqman® gene 
expression Q-PCR master mix was used (Applied Bioscience; Foster City, CA) and all reactions 
were performed in duplicate according to the manufacturer’s instructions. As an internal control, 
mRNA levels of Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) are measured, and all 
data is represented relative to its expression (i.e., using the -Ct method) as fold change from 
SED/H2O group (143).  
3.4.5 Analysis of Lactobacillus bacteria in mucosal scrapings: Mucosal scrapings were 
probed specifically for the genus Lactobacillus 16S ribosomal DNA and quantified by 
quantitative Real Time-PCR (qPCR). Bacterial DNA was isolated as described by Carbonero et 
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al. (144) and stored at -80C until qPCR was performed. Bacteria of the genus Lactobacillus and 
total bacterial DNA was quantified using methodology described by Bailey M (14). Briefly, 
DNA from mucosal scrapings was isolated using the Power Soil DNA isolation kit commercial 
kit (MO BIO Laboratories Carlsbad, CA, #12888-100). Primers for Lactobacillus genre bacteria 
(Forward (LactoF) 5ʹ-AGC AGT AGG GAA TCT TCC-3ʹ, Reverse (LactoR) 5ʹ-CAC CGC 
TAC ACA TGG AG-3ʹ) and general conserved bacterial DNA sequences for 16S ribosomal 
DNA as a normalizer (Forward (8F) 5ʹ-AGA GTT TGA TCC TGG CTC AG-3ʹ, Reverse 
(1541R) 5ʹ-AAG GAG GTG ATC CAG CCG CA-3ʹ) were used (Integrated DNA Technologies, 
IA). Total lactobacilli bacterial gene expression with total bacterial DNA presence (e.g. 
housekeeping gene) was analyzed using the following reaction: 4 µl Power SYBR® Green (cat. 
# 4367659), 1 µl of DNA at a concentration of 5 ng/µl DNA, and 0.1 µl of forward and reverse 
primers per reaction for a total reaction volume of 8 µl. Quantitative Real Time-PCR was 
performed on the 7900HT Fast Real-Time PCR system and SDS Enterprise Database. All 
reactions were performed in triplicate according to manufacturer’s instructions.  
3.4.6 Bacterial Translocation: Mesenteric lymph nodes were harvested and frozen in 
liquid nitrogen. Lymph nodes were homogenized and total DNA was isolated using a 
commercial DNA isolation kit (Power Soil DNA isolation kit; MO BIO Laboratories Carlsbad, 
CA, #12888-100) and stored at -80C until analysis. Finally, isolated DNA was analyzed (using 
the same protocol in section 3.4.5 above) for the presence of bacteria by amplifying bacterial 
DNA conserved sequences (Forward primer 8F: 5ʹ-AGA GTT TGA TCC TGG CTC AG- 3ʹ; 
Reverse primer 1514r: 5ʹ-AAG GAG GTG ATC CAG CCG CA-3ʹ) using quantitative Real 
Time-PCR (7900HT Fast Real-Time PCR system and SDS Enterprise Database). 
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3.4.7 Serum Amyloid A analysis: The acute phase protein serum amyloid A (SAA) 
concentration was measured in plasma by enzyme-linked immunosorbent assay (ELISA), per 
manufacturer instructions (Alpco Diagnostics; Salem, NH), as an indicator of systemic 
inflammation. 
3.5 Statistical Analysis 
Analysis of variance (ANOVA) with repeated measures was be used to determine 
between-group differences in body weight, food and fluid intake as a result of intervention 
(exercise) and treatment (DSS) in treadmill and VWR studies. Univariate one-way ANOVA 
(treatment x intervention) was used to determine between-group differences in thymic weight, 
adrenal gland weight, citrate synthase activity, all colon gene expression, immunohistochemical 
results from macrophage presence in colon sections, total bacterial content in mesenteric lymph 
nodes, quantified presence of Lactobacillus genus in the mucosal scrapings of the proximal 
colon, and serum amyloid A. When a significant main effect was detected at a significance level 
p<0.05, post hoc analyses were performed using Student’s t test. Data that were not normally 
distributed were log transformed to achieve normality. Kruskal- Walls and Mann-Whitney tests 
was used to analyze ranked immunohistochemistry results determining necrosis and 
inflammation. Chi-squared analysis of variables, such as diarrhea incidence and fecal hemoccult 
analysis, was also used. Data was analyzed using SPSS software (v 20.0, Chicago, IL) and for all 
statistical tests, α was set at 0.05. 
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CHAPTER 4 
FORCED TREADMILL EXERCISE TRAINING EXACERBATES INFLAMMATION 
AND CAUSES MORTALITY WHILE VOLUNTARY WHEEL TRAINING IS 
PROTECTIVE IN A MOUSE MODEL OF COLITIS
2
 
 
4.1 ABSTRACT 
The purpose of this study was to examine whether exercise training reduced inflammation and 
symptomology in a mouse model of colitis. We hypothesized that moderate forced treadmill 
running (FTR) or voluntary wheel running (VWR) would reduce colitis symptoms and colon 
inflammation in response to dextran sodium sulfate (DSS). Male C57Bl/6J mice were 
randomized to sedentary, moderate intensity FTR (8-12 m/min, 40 min, 6 weeks, 5x/week), or 
VWR (30 days access to wheels). DSS was given at 2% (w/v) in drinking water over 5 days. 
Mice discontinued exercise 24 h prior to and during DSS treatment. Colons were harvested on 
Days 6, 8 and 12 in FTR and Day 8 post-DSS in VWR experiments. Contrary to our hypothesis, 
we found that moderate FTR exacerbated colitis symptomology and inflammation as measured 
by significant (p<0.05) increases in diarrhea and IL-6, IL-1β, IL-17 colon gene expression. We 
also observed higher mortality (3/10 died vs. 0/10, p = 0.07) in the FTR/DSS group. In contrast, 
VWR alleviated colitis symptoms and reduced inflammatory gene expression in the colons of 
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DSS-treated mice (p<0.05). While DSS treatment reduced food/fluid intake and body weight, 
there was a tendency for FTR to exacerbate, and for VWR to attenuate, this effect. FTR (in the 
absence of DSS) increased gene expression of the chemokine and antibacterial protein CCL6 
suggesting that FTR altered gut homeostasis that may be related to the exaggerated response to 
DSS. In conclusion, we found that FTR exacerbated, whereas VWR attenuated, symptoms and 
inflammation in response to DSS. 
 
Key words:  exercise, inflammation, colitis, stress, treadmill running, voluntary wheel running, 
serum amyloid A, dextran sodium sulphate, inflammatory bowel disease 
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4.2 INTRODUCTION 
Inflammatory bowel diseases (IBD), such as ulcerative colitis (UC), cause chronic 
morbidity that significantly reduce physical functioning and quality of life in afflicted patients. 
While UC is an idiopathic disorder, it is clear that environmental (e.g. infection, diet, 
psychological stress) and host genetic factors, in combination with disturbances in the intestinal 
microbiome, trigger barrier disruption leading to dysregulated inflammation in response to 
resident gut bacteria (Sanchez-Munoz et al., 2008). Immune cell infiltration stimulates the 
production of pro-inflammatory cytokines, which promote a chronic inflammatory state, 
instigating clinical symptoms including colon ulcers, rectal bleeding, diarrhea, abdominal pain, 
fatigue, and an overall altered emotional well-being
 
(Sanchez-Munoz et al., 2008). Furthermore, 
UC significantly increases the risk of developing colorectal cancer later in life (Rizzo et al. 
2011). 
It is well established that anti-inflammatory therapies, designed to decrease colon 
inflammation, attenuate the symptoms of UC in humans and mouse models of the disease (Bi 
and Triadafilopoulos, 2003). Anti-inflammatory pharmaceutical treatments, such as 5-
aminosalicylic acid and corticosteroids, are beneficial in reducing symptoms, but their efficacy is 
not complete and they have significant side-effects. Therefore, in addition to more efficacious 
and safer drug development, investigation of adjunct anti-inflammatory therapies that could 
attenuate colitis and counteract side effects of conventional treatment is of prime importance 
from a public health perspective. Such strategies could assist in improving the quality of life by 
reducing symptoms, hospitalizations, and the risk of colorectal cancer in UC patients. 
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Exercise has been suggested as an adjunct anti-inflammatory therapy for chronic diseases 
associated with inflammation (Astrom et al., 2010). Indeed, our laboratory as well as others, 
have provided evidence that moderate treadmill exercise acts in an anti-inflammatory fashion 
and bolsters immunity in humans (Vieira et al., 2009a; Packer et al., 2010; Walsh et al., 2011) 
and in animals where exaggerated or chronic inflammation exists (Lowder et al., 2006; Keylock 
et al., 2008; Vieira et al., 2009b). With respect to the gut, while there is significant evidence that 
regular moderate exercise can reduce risk for colon cancer, there are very few studies on whether 
it can exert positive effects in people with IBD. However, there is evidence that prolonged, 
intense exercise bouts can cause debilitating gastrointestinal complaints including cramps, 
diarrhea and gut inflammation most likely due to gut ischemia and/or mechanical trauma (Bi and 
Triadafilopoulos, 2003; Packer et al., 2010). Results from the few observational studies of 
exercise and IBD reveal that regularly performed moderate exercise neither protects from nor 
initiates IBD (Narula et al., 2008). However, definitive randomized exercise trials are lacking.   
When given in the drinking water to rodents, DSS induces reproducible lesions in the 
distal colon by interfering with barrier function and stimulating local inflammation mimicking 
the pathophysiology of human colitis (Laroui et al., 2012). Although models such as DSS-
induced colitis do not represent the complexity of the human disease, investigating intestinal 
inflammation in animal models has produced valuable data that have been useful in uncovering 
signaling pathways during colon inflammation (Fukuta et al., 2005), the cell types and cytokines 
responsible for disease activity (Elrod et al., 2005), and the local and systemic pathophysiology 
of acute and chronic colitis (Mizoguchi et al., 2003; Wirtz et al., 2007; Hamandi et al., 2008). 
Additionally, these models are valuable and indispensable tools for manipulating factors that 
affect pathogenesis and evaluating potential therapeutic strategies (Wirtz et al., 2007). Therefore, 
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given the lack of knowledge in this area, the purpose of our study was to investigate the effect of 
moderate forced treadmill and voluntary wheel running on DSS-induced colitis mortality, 
morbidity, colon inflammation and colon histopathology in mice. We hypothesized that exercise 
would reduce symptoms and inflammatory burden in the colon in response to DSS. 
4.3 METHODS 
Animals. Eight to ten week old male C57Bl/6J mice (forced treadmill run [FTR], n=132; and 
voluntary wheel run [VWR], n=26) were purchased from Jackson Laboratories (Bar Harbor, 
ME) and singly housed in an accredited specific pathogen-free (SPF) barrier facility. Animals 
were housed under a reverse light-dark cycle (lights on at 9 PM, lights off at 9 AM) in a low 
stress environment and given ad libitum access to sterile water (unless on study) and autoclaved 
rodent chow. Mice were acclimated to the facility for 1 week prior to the experiments. All 
corncob bedding and cages were sterilized before use and were changed weekly. All experiments 
were approved by the University of Illinois Urbana-Champaign IACUC. Three separate FTR 
experiments were performed with euthanasia occurring at Day 6 (n=10/group), Day 8 
(n=13/group) or Day 12 (n=10/group) post-DSS treatment. The VWR experiment was performed 
with euthanasia occurring at Day 8 post-DSS at the time of peak symptoms (control: n=5/group; 
DSS: n=8/group).  
Exercise Protocol. For the FTR experiments, mice were paired on body weight prior to training 
or sedentary control conditions and then randomized into one of four groups; sedentary water 
(SED/H2O), sedentary DSS (SED/DSS), exercised water (FTR/H2O) and exercised DSS 
(FTR/DSS). Mice (including exercise trained mice) did not run during or after DSS treatment to 
minimize distress. Using this design, we were interested in testing the effects of prior exercise 
training on response to DSS-induced colitis. FTR mice performed 6 weeks (5 days/week: total 30 
40 
 
sessions) of forced moderate treadmill running (8-12 m/min; 5% grade; equating to ~480m of 
running per session) for 40 minutes per day at the beginning of their dark cycle prior to DSS 
treatment. For the VWR experiment, mice were housed in cages with free access to telemetered 
running wheels (Respironics, Bend, OR) for 30 days. Thus, we controlled for the number of days 
of exposure to exercise, but not exercise intensity or volume between the two different exercise 
paradigms. The last exercise session occurred 24 hours prior to DSS administration. All 
sedentary mice were handled similarly and housed in close proximity to the treadmill and wheel 
cages during the exercise training to control for incidental stress associated with handling, noise 
and novel environmental exposure.  
DSS Treatment. Regular drinking water was replaced by 2% DSS in sterile water (w/v, MP 
Biochemical 36,000-50,000 MW) for a period of 5 days after completion of the exercise 
intervention period. The DSS solution was monitored daily, refilled appropriately and replaced 
on Day 3.  
Morbidity. Daily measurements of body weight and food and fluid intake were made during and 
after DSS administration. In addition, mouse feces were evaluated in an observer blinded manner 
for consistency/diarrhea (e.g. formed pellet vs. semi-formed/soft) and were tested daily for the 
presence of blood (Hemoccult®). Lastly, we assessed the physical activity behavior (e.g. 1 = 
‘normal, 2 = ‘slight reduction’, 3 = ‘limited’, 4 = ‘immobile’) in the home cage and response to 
capture (e.g. 1 = ‘normal evasion’, 2 = ‘some evasion’, 3 = ‘no evasion’) as indicators of 
sickness behavior in a blinded manner.   
Tissue Collection. Mice were euthanized by rapid CO2 asphyxiation and cervical dislocation. 
Blood was drawn from the inferior vena cava and stored on ice. Plasma was separated and stored 
at -80⁰C. Mice were then perfused via intra-cardial injection of sterile saline. The colon was 
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removed (distal to the caecum to the anus) and colon length was assessed using digital calipers 
(Tresna) to the nearest mm. Mesentery tissue was removed from the colon which was flushed 
with PBS and separated into proximal and distal ends. A 2 cm piece was cut from the top portion 
of the distal half and fixed in 10% buffered formalin until sectioning for histological analysis. 
Proximal and distal ends were stored at -80⁰C until analysis. Both adrenals and the thymus were 
excised and weighed to screen for adrenal hypertrophy and thymic involution. 
Colon Histological Analysis. The 2 cm long 10% formalin fixed colon samples were paraffin 
embedded and 3 μm cross sections were stained with hematoxylin and eosin. Colon damage 
(necrosis) and immune cell infiltrate was scored by a blinded observer based on a published 
scoring system that considers architectural derangements, goblet cell depletion, 
edema/ulceration, and degree of inflammatory cell infiltrate (Wirtz et al., 2007). Each sample 
was ranked twice, once for necrosis and once for inflammation. Scoring for inflammatory cell 
infiltration was as follows: 0 = ‘normal’, 1 = ‘mild’, 2 = ‘moderate’, 3 = ‘severe’. Necrosis was 
scored as: 0 = ‘normal’, 1 = ‘mild’ (~1-25% necrotic), 2 = ‘moderate’ (~26-75% necrotic), 3 = 
‘severe’ (>75% necrotic). 
Analysis of Gene Expression. Quantitative real-time polymerase chain reaction (qRT-PCR) was 
used to determine gene expression in colon tissue samples. Approximately 30 mg of each colon 
sample was homogenized using a tissue homogenizer (PRO Scientific PRO-250 rotary). RNA 
was extracted using the Applied Bioscience protocol (Applied Bioscience, Carlsbad, CA) and 
stored at -80C. Later, the reverse transcriptase reaction was performed using commercial first 
strand kits (Applied Biosciences, CA) and random hexamer primers, as described in the 
manufacturer’s protocol. The RNA sample concentrations and purities were analyzed 
spectrophotometrically. Gene expression was analyzed using a qRT-PCR machine (7900HT Fast 
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Real-Time PCR system and SDS Enterprise Database). We assessed both pro- (IL-1β, TNF-α, 
IL-6, IL-17A) and anti-inflammatory (IL-10) cytokines in the colon as markers of classic 
immune response (Applied Biosciences primers: IL-1β, Mm00434228; TNF-α, Mm00443258; 
IL-6, Mm00446190; Mm00518984; IL-17A, Mm00439618; IL-10, Mm00439616). 
Inflammatory cytokines such as IL-1β, TNF-α, and IL-17A have been implicated in the 
pathogenesis of UC and correlate with disease activity (Papadakis and Targan, 2000; Sanchez-
Munoz et al., 2008; Malik and Mannon, 2012). IL-17A was measured because it is a potent 
cytokine involved in gut defense against bacteria that recruits neutrophils and stimulates 
epithelial defensin production, but also drives a T cell response that causes tissue damage in the 
gut (Monteleone et al., 2009). . Chemokines direct immune cell traffic (Kotarsky et al., 2010), 
exhibit anti-microbial properties (Coelho et al., 2007), and are attractive targets for the 
management of IBD because they are highly expressed chemokine in the inflamed colon of IBD 
patients, thus we measured the chemokine CCL6 (Atreya and Neurath, 2010) (Applied 
Biosciences primer: Mm01302419) and the neutrophil chemotactic CXCL1 (Puleston et al., 
2005) (Applied Biosciences primer: Mm04207460). To perform the PCR reactions, Taqman® 
gene expression Q-PCR master mix was used (Applied Bioscience, CA). As an internal control, 
mRNA levels of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Su et al., 2007) were 
measured and all data are represented relative to its expression (i.e., using the -Ct method) as 
fold change from SED/H2O group (Livak and Schmittgen, 2001).  SED/H2O values from Day 6 
are considered referent to allow for comparison between the different days of the FTR studies. 
Serum Amyloid A (SAA). The acute phase protein serum amyloid A (SAA) concentration was 
measured in plasma by enzyme-linked immunosorbent assay (Alpco Diagnostics; Salem, NH) as 
an indicator of systemic inflammation.   
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Statistical Analysis. Analysis of variance (ANOVA) with repeated measures was used to 
determine between and within-group differences in body weight, and food and fluid intake as a 
result of intervention (exercise) and treatment (DSS). In the Day 12 experiment, 3 of 10 mice in 
the FTR/DSS group were lost to mortality (n = 2 on Day 8 and n = 1 on Day 10). We utilized the 
last observation carried forward (LOCF) procedure to be able to compute repeated measures 
analyses for these variables so as not to omit data from the sickest animals.  The Log-rank 
(Mantel-Cox) test was used to test differences in survival. At a given time point, two-way 
(intervention x treatment) ANOVA were used to determine between-group differences in colon 
gene expression (e.g. IL-1β, IL-6, TNF-α, CCL6, CXCL1, and IL-10), and serum amyloid A. 
When a significant main effect was detected at a significance level p<0.05, post hoc analyses 
were performed using Bonferroni corrected Student’s t test. Data that were not normally 
distributed (as tested by the Kolmogorov-Smirnov test) were log transformed. Nonparametric 
analyses (Kruskal-Wallis & Mann-Whitney rank sum) were used to detect between-group 
differences in histological assessment of necrosis and inflammation, IL-6, IL-1, TNF-α in VWR 
mice, IL-17 gene expression on Days 6 and 8 in FTR mice.  All gene expression data are 
represented relative to the expression of GAPDH (i.e., using the -Ct method) and reported as 
fold change from the Day 6 SED/H2O referent group in the FTR experiments. Data were 
analyzed using SPSS software (v 20.0, Chicago, IL) and for all statistical tests, α was set at < 
0.05.  
4.4 RESULTS 
Effects of FTR on DSS-induced changes in mortality and morbidity.  
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Mortality. No animals died due to DSS-treatment in the Day 6 or Day 8 experiments. 
However, in the Day 12 experiment, 3/10 mice died (two on Day 9 and one on Day 11) in the 
FTR/DSS group while none (0/10) died in the SED/DSS group. The Log-rank (Mantel-Cox) test 
revealed a tendency (χ2 = 3.3, p = 0.069) for higher mortality in the FTR/DSS group. 
Body weight loss, food and fluid intake.  Indicative of the moderate intensity of the FTR, 
there were no significant differences in body weight (29.65 ± 0.47, 28.88 ± 0.40 g for SED and 
FTR, respectively) after the 6 wk FTR intervention, but there was both a time (F5,185 = 1901, p = 
0.000) and a time x intervention interaction (F5,185 = 4.8, p = 0.000) suggesting that the FTR mice 
gained weight at a slower rate than the sedentary mice over the course of the 6 week FTR 
intervention (data not shown). To best represent the changes in body weight over time in 
response to DSS, we present data from the Day 12 experiment only (Figure 4a). DSS treatment 
resulted in significant weight loss beginning at Day 6 onward in both treated groups (Figure 4a). 
While FTR/DSS lost more body weight than SED/DSS, there was only a tendency (p = 0.14) for 
a time x treatment x intervention interaction. For fluid intake in the Day 12 experiment, DSS 
reduced fluid intake on Days 4-8 post-DSS, but there was no significant time x treatment x 
intervention interaction even though fluid intake was lower in FTR/DSS on Days 5 and 6 post-
DSS (Figure 4b).  It is important to note that there were no significant differences in fluid intake 
between SED/DSS and FTR/DSS indicating similar exposure to DSS. Food intake was 
significantly reduced on Days 5-7 post-DSS, but there was no time x treatment x intervention 
indicating no differences in food intake between the FTR/DSS and SED/DSS groups (data not 
shown). 
FTR Colitis Symptoms. While DSS reduced physical activity behavior in the home cage, 
response to capture and blood in the feces (Table 1), we observed no significant differences in 
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these measures when comparing SED and FTR (other data not shown). However, FTR resulted 
in significant increase in the incidence of diarrhea on Days 7-9 post-DSS when compared to SED 
(Day 7 χ2 = 10.3, p = 0.001; Day 8 χ2 = 7.1, p = 0.008; Day 9 χ2 = 10.8, p = 0.001) (Table 1). 
There was no diarrhea detected in any of the H2O control groups. 
Effects of FTR colon cytokine gene expression. As expected, DSS increased pro-inflammatory 
cytokine gene expression in the colon (Figure 5). Interestingly, and in contrast to our hypothesis, 
moderate FTR led to an exacerbated pro-inflammatory cytokine gene response to DSS including 
significant increases in IL-1β (F1,45 = 15.2, p = 0.000 for interaction) and IL-6 (F1,45 = 5.4, p = 
0.02 for interaction) (Figure 5 a and c) at Day 8 post-DSS. While there were no statistically 
significant interactions, TNF-α mRNA expression was higher in the FTR mice on Days 6 and 8 
(Figure 5b). IL-17 gene expression was also exacerbated by FTR at Day 8 post-DSS (p = 0.001) 
(Figure 5d). Although not significant, by Day 12, the FTR group demonstrated lower Il-1β and 
IL-17 gene expression when compared to sedentary controls. This could be due to the death of 3 
mice in the FTR group who likely expressed IL-1β and IL-17 at high levels. IL-10, an anti-
inflammatory cytokine, was also significantly (F1,45 = 4.9, p=0.03) higher in colons of the FTR 
group at Day 8 and tended to be higher at Day 12 (Figure 5e). IL-10 mRNA tended to be higher 
in the FTR groups at Day 12. . 
Effects of FTR on CCL-6 and CXCL1 gene expression in the colon. DSS tended (p = 0.07) to 
reduce CCL6 mRNA expression on Day 6 and significantly increased it on Day 8 (F1,45 = 5.85, p 
= 0.02) (Figure 6a). The most striking finding was that moderate intensity FTR significantly 
increased colonic CCL6 gene expression across all experiments (e.g. significant FTR main 
effects seen at each day; Day 6: F1,36 = 5.5, p = 0.025; Day 8: F1,45 = 12.0, p = 0.001; Day 12:  
F1,32 = 4.6, p = 0.04) when compared to SED/H2O. CXCL1 mRNA expression was only 
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measured at Day 8 revealing a significant (F1,48 = 71.0, p=0.000) DSS treatment effect and a 
tendency (p=0.07) for a difference between SED/DSS and FTR/DSS (Figure 6b). 
Effects of FTR on DSS-induced histopathology. We examined hematoxylin and eosin stained 
colon cross-sections and scored them for necrosis and inflammation (see methods). 
Representative images (5X magnification) can be found in Figure 7a-d. Control water groups 
(SED/H2O and FTR/H2O) are represented and show normal histology. However, DSS-treated 
groups (SED/DSS and FTR/DSS) show signs of edema (E), inflammation (I), and necrosis (N).  
Quantification revealed that DSS increased necrosis (Figure 7e) and inflammation (Figure 7f) 
scores across all days; however, we found no intervention x treatment interactions. Necrosis and 
inflammation scores tended to be lower in non-DSS treated FTR mice and significantly so at Day 
8 for necrosis (Figure 7e). 
Effects of DSS and FTR on Serum Amyloid A (SAA). In the FTR experiments, SAA was only 
measured on Days 8 and 12 post-DSS in a subset of mice. SAA increased significantly (F1,26 = 
18.5, p < 0.001) in response to DSS on Day 8 (112 + 15, 84 + 7, 183 + 35, and 356 + 54 µg/mL 
for SED/H2O, n=5; FTR/H2O, n=5; SED/DSS, n=7 and FTR/DSS, n=13, respectively) and was 
still significantly (F1,20 = 14.2, p = 0.001) elevated at Day 12 (112 + 15, 79 + 7, 129 + 5, and 273 
+ 62 µg/mL for SED/H2O, n=5; FTR/H2O, n=5; SED/DSS, n=7 and FTR/DSS, n=7, 
respectively).  FTR significantly (F1,26 = 4.9, p = 0.036) exacerbated this effect on Day 8.  
Effects of VWR training on DSS-induced changes in mortality and morbidity. 
As we found differences in the FTR experiment, we chose to examine the effects of 
VWR on DSS-induced colitis in a separate experiment where animals were sacrificed at Day 8 
post-DSS at the time of peak symptoms and colon inflammation.  
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Mortality. No animals in the VWR experiment died through Day 8 post-DSS, the time at 
which the experiment was terminated for euthanasia and tissue collection. 
Body weight loss, food and fluid intake. After the 30 day VWR intervention in which 
mice ran 6.32 ± 0.25 Km/day on average, VWR mice (23.7 + 0.3 g) weighed significantly (t24 = 
2.9, p = 0.007) less than sedentary (25 + 0.3 g) mice indicative of a VWR training effect on body 
mass. DSS treatment significantly (time x treatment F7,154 = 6.3, p = 0.001) reduced body weight 
on Days 6 and 7, but there was no intervention x treatment x time interaction (Figure 8a). 
However, close inspection revealed that VWR/DSS mice began to regain body weight on Day 7 
whereas SED/DSS mice continued to lose weight. This, along with the fact that VWR/H2O 
gained weight, was reflected in a tendency for a time x intervention (p = 0.13) and an 
intervention main effect (p = 0.06). Fluid intake (Figure 8b) was also reduced by DSS treatment 
(F6,132 = 4.8, p = 0.000) at Day 6 without a time x treatment x intervention interaction indicating 
that both VWR and SED groups responded similarly to DSS-induced fluid intake reduction. 
However, there was an intervention and time x intervention interaction, indicating that VWR 
groups had greater fluid intake in particular at Days 6 and 7. Food intake tended to be reduced by 
DSS, but there was no time x treatment x intervention indicating no differences in food intake 
between the FTR/DSS and SED/DSS groups (data not shown). 
VWR Colitis Symptoms. As was the case in the FTR experiment, DSS reduced physical 
activity behavior in the home cage, response to capture, and bloody stools (Table 1) but there 
were no significant differences in these measures when comparing SED and VWR (other data 
not shown). Diarrhea was present in DSS treated mice starting on Day 5 and, in contrast to FTR, 
was significantly less in the VWR mice (χ2 p values < 0.05) on Days 6-7 when compared to their 
sedentary counterparts (Table 1).   
48 
 
Effects of VWR training on DSS-induced colon cytokine gene expression. IL-1β mRNA, while 
elevated, was not statistically different (p = 0.11) when compared to H2O-treated groups (Figure 
9a).  There were no differences in IL-1β DSS responses between SED and VWR groups, but 
there was a tendency (p = 0.09) for IL-1β to be lower between VWR/H2O and SED/H2O. TNF-α 
cytokine gene expression was significantly increased in DSS-treated mice (Figure 9b). In 
contrast to FTR, VWR led to a significantly lower colonic TNF-α cytokine gene response to DSS 
(p = 0.005). There was a tendency (p = 0.10) for IL-6 mRNA to be increased in response to DSS 
and there was a significant (p = 0.001) difference between SED/DSS and VWR/DSS groups 
(Figure 9c). DSS tended to increase IL-17 (p = 0.06) and significantly increased IL-10 (F1,22 = 
4.58, p= 0.044) gene expression (Figure 9d-e). While IL-17 and IL-10 gene expression were 
lower in VWR/DSS compared to SED/DSS, there were no statistical differences.  
Effects of VWR on DSS-induced CCL-6 and CXCL1 gene expression in the colon. In contrast 
to FTR, CCL6 gene expression was not significantly altered by VWR independent of DSS 
treatment (Figure 10a) nor was it increased by DSS when measured at Day 8. Gene expression 
of the neutrophil chemokine CXCL1 was significantly increased with DSS (F1,22 = 13.2, p = 
0.000) and, while lower in VWR/DSS, was not significantly different (p = 0.23) from SED/DSS 
(Figure 10b).  
Effects of VWR training on DSS-induced histopathology. Representative hematoxylin and 
eosin stained images (5X magnification) can be found in Figure 11a-d. Control water groups 
(SED/H2O and VWR/H2O) are represented and show normal histology (LN = normal lymphoid 
nodule). Colitis groups (SED/DSS and VWR/DSS) show signs of glandular elongation (GE) and 
atrophied mucosa (AM) due to loss of goblet cells, inflammation (I), and necrosis (N). Mann-
Whitney Rank-Sum analysis revealed significant colon necrosis (Figure 11e) and inflammation 
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(Figure 11f) on Day 8 post-DSS (treatment p < 0.001 for both), however, we found no 
differences between sedentary and VWR DSS-treated groups. 
Effects of DSS and VWR on Serum Amyloid A (SAA). SAA increased significantly (F1,19 = 
40.7; p = 0.000) in response to DSS (112 + 15, 109 + 6, 237 + 10, and 324 + 42 µg/mL for 
SED/H2O, n=5; VWR/H2O, n=5; SED/DSS, n=5 and VWR/DSS, n=8, respectively), however 
there were no differences between SED/DSS and VWR/DSS groups.  
Effects of FTR and VWR on indices of chronic stress. In a separate experiment in water only-
treated FTR and VWR mice, we measured thymic and adrenal weights 24 hrs after the last 
training session to determine whether these different exercise paradigms affected stress-sensitive 
measures. Chronic stressors lead to thymic involution and adrenal hypertrophy in mice (Moraska 
et al., 2000). FTR mice had significantly larger adrenal (t18 = 2.4, p = 0.03) and lower thymic 
gland (t18 = 4.0, p = 0.001) weights when compared to SED mice (Figure 12a-b). However, 
there were no differences when comparing sedentary and VWR mice in thymic or adrenal gland 
weights.  
4.5 DISCUSSION 
Contrary to our hypothesis, we found that 6 weeks of prior forced moderate treadmill 
running (FTR) exacerbated inflammatory gene expression in the distal colon and increased 
hepatic acute phase SAA in the systemic circulation in response to DSS. This was accompanied 
by increased morbidity (e.g. diarrhea) and mortality. These negative findings led us to investigate 
whether voluntary wheel running (VWR) elicited similar effects. In contrast, we found that 30 
days (e.g. same number of days of exposure as FTR) of VWR significantly attenuated 
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inflammatory gene expression in the distal colon and protected mice from DSS-induced 
morbidity in that VWR/DSS-treated mice experienced reduced diarrhea.  
Similar to our FTR results, chronic psychosocial stress has been shown to exacerbate 
colitis in the DSS mouse model. For example, Reber et al exposed mice to repeated social defeat 
and overcrowding stress for 19 consecutive days and found more severe symptoms and colon 
inflammation in response to 1% DSS (Reber et al., 2006).Therefore, it is likely that the FTR we 
applied in this study was perceived by mice as a chronic stressor even though the duration was 
short and the intensity of exercise was moderate. In support of this, we measured adrenal and 
thymic gland weights in response to FTR and VWR and found that only FTR resulted in adrenal 
hypertrophy and thymic atrophy. Our findings are similar to that of Moraska et al. who found 
that 8 wks of FTR (for longer durations and higher intensities than we applied), while inducing 
beneficial changes in body weight and muscle metabolism, caused potentially detrimental 
changes in the adrenal and thymic glands of rats (Moraska et al., 2000). 
It is interesting to note that, in our hands, FTR is detrimental in terms of exacerbating 
inflammation in the DSS-induced mouse model of colitis, but exerts beneficial anti-inflammatory 
effects in other models of inflammation-associated morbidity. Indeed, we have published that 
similar FTR protocols in mice can reduce adipose and systemic inflammation in response to 
high-fat diet feeding (Vieira et al., 2009b, 2009c) and Kohut’s group has demonstrated that 14 
wks of FTR reduced lung inflammation and improved symptoms in response to influenza virus 
infection (Sim et al., 2009) in mice. Moreover, 12 wks of FTR has been shown to repress 
neuroinflammation in the brains of mice transgenic for human tau23; a model of Alzheimer’s 
disease (Leem et al., 2011). The reasons for the differential effects of FTR on inflammation in 
these models are unclear; however it may have to do with the tissue being analyzed. The gut is 
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highly innervated with both sympathetic and parasympathetic nerves, has its own enteric nervous 
system, contains a vast array of immune cells, and is at the interface of the ‘outside world’; a 
location where significant numbers of bacteria exist. This anatomy may make it different from 
other tissues as it relates to effector responses to stress. Indeed, psychological stress in humans is 
associated with perturbations in gut physiology and related to conditions such as irritable bowel 
syndrome and ulcerative colitis (O’Malley et al., 2011; Reber et al., 2006). 
Aside from the forced or voluntary nature of the exercise, there were large differences in 
the volumes and perhaps intensities of exercise between the two paradigms. Given that mice in 
our VWR group ran ~4-8Km during the typical 8-10 h period of their dark cycle each day, it is 
clear that experiments are needed to titrate this wheel running effect. That is to say, ‘can lower 
volumes of VWR result in beneficial effects in this DSS mouse model of colitis?’ In an attempt 
to indirectly address this, we correlated VWR distance with DSS colitis outcomes including 
inflammatory gene expression and morbidity and we failed to document any statistically 
significant correlations (data not shown). However, it should be noted that the animal that ran the 
least on average still ran ~4km/day. This may be well above a threshold volume to see VWR 
effects. It is interesting that such a low volume (e.g. 40min/day) and intensity (8-12 m/min or ~ 
60-75% VO2max) (Schefer and Talan, 1996) of FTR had negative effects while high volumes of 
exercise associated with VWR had beneficial effects. This contrasts the human literature 
demonstrating the prolonged, intense exercise can lead to gut dysfunction but moderate exercise 
may be beneficial (Martin, 2011). As mentioned above, a critical factor is likely the forced 
versus voluntary nature of the exercise paradigms. Future experiments will need to equate the 
dose (e.g. intensity and volume) of exercise between the two paradigms in order to tease out 
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whether the nature of the exercise (e.g. forced vs. voluntary) or the exercise dose is the important 
factor.  
There are several possible mechanisms for this detrimental effect of uncontrollable FTR 
on DSS-induced colitis.  First, recent studies in animals examining the effects of chronic stress 
have demonstrated that it can cause spontaneous colitis and exacerbate chemically-induced 
colitis (Reber et al., 2006). In these studies, colitis development or exacerbation was associated 
with loss of anti-inflammatory glucocorticoid signaling and tissue sensitivity (Reber, 2012). Data 
such as these point to a critical role of the HPA axis in regulating UC. Although untested in the 
present experiment, FTR may induce a state of glucocorticoid resistance allowing for 
exaggerated and chronic inflammation in response to DSS. Second, we found that FTR caused a 
significant and long-lasting (at least 12 days after the last exercise session) elevation in CCL6 
mRNA expression in non-DSS treated mice. This chemokine is chemotactic for innate immune 
effector cells such as dendritic cells and macrophages (Coelho et al., 2007) and is secreted by 
intestinal epithelial cells where it possesses antibacterial functions (Kotarsky et al., 2010). Thus, 
it may be that FTR, but not VWR, increases bacterial translocation from the gut lumen into the 
mucosal layers initiating anti-bacterial defense mechanisms such as increased CCL6 expression. 
One hypothesis would be that FTR, by increasing CCL6 chemokine expression, increased 
migration of dendritic cells and macrophages to the colon. This elevation in colonic innate 
immune cells could be responsible for the exaggerated inflammatory response to DSS seen in 
these FTR mice. We are currently exploring whether FTR (or VWR for that matter) in the 
absence of DSS exposure alters the number of innate immune cells in the colon or translocation 
of bacteria to mesenteric lymph nodes. 
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In addition to demonstrating a negative effect of moderate amounts of FTR, what is novel 
about our study is that 30 days of VWR resulted in beneficial effects, to the extent that VWR 
almost completely abrogated DSS-induced pro-inflammatory gene expression in the distal colon. 
This finding is important in that it supports a role for exercise in the adjunct treatment of 
ulcerative colitis in humans. While VWR has been shown to be anti-inflammatory in other 
models, there is less evidence regarding its role in the gut. In support of lower volumes of VWR 
acting beneficially in a colitis model, Kasimay et al. demonstrated that 200m of VWR, 3 times 
per week, for 6 wk reduced macro- and microscopic damage scores, myeloperoxidase activity (a 
marker of inflammation) and malondialdehyde (a marker of oxidative stress) in rats given 
intracolonic acetic acid (Kasimay et al., 2006). The authors noted that these effects were 
associated with a decrease in anxiety-like behavior. Clinical symptoms or more direct measures 
of inflammation were not reported. Recently, Saxena et al. (Saxena et al., 2012) reported that 
FTR did not affect clinical scores or ex vivo IL-1β, IL-6 or IL-10 protein production and reduced 
TNF-α protein production in response to DSS-induced colitis; findings that contrast our results. 
This was surprising given the many similarities (e.g. mouse strain, DSS treatment) between 
experiments. One difference was that their FTR protocol involved ~1080-1320m of running per 
day compared to ~480m in our study (> 2-fold difference) and their training duration was 4 wk 
vs. our 6 wk long paradigm. Whether or not the higher dose of exercise somehow protected their 
mice from the detrimental stress effect or their training duration was too short to see a 
detrimental effect remains to be determined. Another difference was that they analyzed ex vivo 
cytokine production from tissue obtained from the transverse colon whereas we measured gene 
expression in the descending colon. It is the descending (distal) colon that is most affected by 
DSS in mice (Perse and Cerar, 2012) and UC in humans (Danese and Fiocchi, 2011). Studies 
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from Hoffman-Goetz et al have found that 16 wk of VWR reduces intestinal lymphocyte 
production of pro-inflammatory and increases production of anti-inflammatory cytokines in the 
absence of any inflammatory stimulus (Hoffman-Goetz et al., 2010). The mechanisms for these 
anti-inflammatory effects of exercise in the gut are unknown, but may involve activation of the 
parasympathetic cholinergic anti-inflammatory reflex (Van Der Zanden et al., 2009). In some 
instances (e.g. IL-1β and TNF-α) we observed trends towards anti-inflammatory effects of VWR 
in non-DSS treated mice consistent with this hypothesis (Fig. 9a & 9b). 
There exist some limitations to the current study. It is interesting to note that while we 
found significant effects in pro-inflammatory gene expression, we failed to document corollary 
changes in inflammation using cross-sectional histological techniques despite our best efforts to 
perform these in a systematic fashion. We also measured colon length as a proxy for 
inflammation, and while DSS resulted in colon shortening, there were no differences between 
SED and either FTR or VWR groups (data not shown). Tissue necrosis (also measured 
histologically), was increased by DSS, but not altered by FTR or VWR. Laroui et al. (Laroui et 
al., 2012) described the mechanism of action of DSS as forming complexes with medium chain 
fatty acids (MCFA) produced by bacteria present in the microflora. Thus, lesions occur where 
these MCFA producing bacteria are colonized making it difficult, using cross-sectional 
histological analysis, to consistently capture areas where more damage has occurred. Therefore, 
longitudinal histological analysis may be necessary to overcome this limitation. Nevertheless, 
our current histological evaluation verified colitis in DSS treated animals. A potential confound 
existed in that differences existed in SED/DSS control diarrhea incidence rates between the FTR 
and VWR experiments. This variable was the only variable that differed statistically amongst the 
control groups of the two separate experiments. This diarrhea incidence difference was not due 
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to differences in DSS administration (e.g. lot or dose) or to the age of the mice in the different 
experiments. However, two different research assistants who were trained identically in diarrhea 
scoring and blinded to treatment performed the diarrhea assessments in the different 
experiments. Whether this control group difference was due to different raters or to true inter-
experimental biological variability is unknown. However, we are confident in our diarrhea 
outcome data because within any given experiment (e.g. FTR or VWR) this rating of diarrhea 
score was consistent and performed by the same ‘blinded to treatment’ rater. Lastly, we 
examined the effects of VWR only at Day 8. We reasoned that this would be the best time to 
compare the effects of VWR because this was the time of peak symptoms and colonic 
inflammation. Based upon our FTR experiment we would expect VWR effects to be smaller 
when measured at other time points.  
UC affects up to 0.25% of the US population or ~750,000 people (Kappelman et al., 
2007) and thus is a significant problem. While pharmaceuticals such as 5-aminosalicylic acid and 
corticosteroids can be of benefit, they are associated with negative side-effects and 10-30% of 
patients still require colon surgery to treat their disease. Unfortunately, there is very little 
information of the role that regular exercise may play in alleviating UC burden. Demonstration 
of proper exercise dosages that could alleviate UC symptoms, reduce colon inflammation, and 
counteract negative side-effects of pharmaceutical therapy would go a long way in convincing 
gastroenterologists and UC patients to adopt this lifestyle strategy as an adjunct therapy in their 
UC treatment. Unfortunately, to date, there is little information regarding the effects of regular 
exercise on IBD’s such as UC. This is surprising given that UC increases risk for subsequent 
colon cancer and that exercise has been found to be protective against colon cancer. To our 
knowledge, there is only one published randomized clinical trial that has examined the influence 
56 
 
of exercise on UC symptoms (Elsenbruch et al., 2005). Unfortunately, exercise (1 time/week) 
was but one of several components (e.g. Mediterranean diet, stress management, other behavioral 
and self-care strategies) of a mind-body intervention. In this 10 wk intervention, Elsenbruch et 
al. (Elsenbruch et al., 2005) found significantly higher mental and physical health scores and 
significantly greater improvements on the Inflammatory Bowel Disease Questionnaire (IBDQ) 
than controls post-intervention. Unfortunately, no disease-specific objective markers (e.g. # of 
UC flares, stool lactoferrin, blood CRP) were measured. This study, and our pre-clinical data 
demonstrating a beneficial effect of VWR on DSS-induced colitis in mice, makes a case for 
exploring the use of exercise as an adjunct treatment for UC. In summary, we report that 6 wk of 
FTR exacerbates, while VWR attenuates inflammation and symptoms associated with DSS-
induced colitis.  
This work supported by American College of Sports Medicine Foundation Doctoral 
Student grants to M.D. Cook and NIH grant (AG029573-S1) to KW Kelley. 
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4.7 FIGURE LEGENDS, TABLES, AND FIGURES 
Table Caption 
Table 1. Effects of prior FTR on diarrhea incidence and fecal blood in DSS-treated mice. 
Data are reported as percentage. There was no diarrhea or fecal blood in water treated groups. 
There was a significant (*) increase in diarrhea incidence between FTR/DSS and SED/DSS on 
Days 7-9 (χ2 p < 0.05) post-DSS administration. There was a significant (*) reduction in diarrhea 
incidence between VWR and SED on Days 6-7 (χ2 p < 0.05) post-DSS administration. N = 8-13 
mice/group for FTR and n = 8-10 mice/group for VWR. 
Figure Legends 
Figure 4.  Effects of prior FTR training on a) body weight loss and b) reduced fluid intake 
induced by DSS. While DSS induced significant weight loss beginning at Day 5 (signified by 
*), there were no time x intervention x treatment (p = 0.14) or intervention x treatment (p = 0.09) 
interactions. DSS reduced fluid intake beginning at Day 4, but there was no difference between 
FTR and SED (p = 0.88 for interaction). N’s = 9, 10, 10 and 10 for SED/H2O, FTR/H2O, 
SED/DSS, FTR/DSS, respectively. 
Figure 5. Colon cytokine gene expression in response to DSS in SED and FTR mice. a) IL-
1β, b) TNF-α, c) IL-6, d) IL-17, and e) IL-10. *denotes significant DSS-induced difference vs. 
SED/H2O controls; # denotes significant difference between FTR/DSS and SED/DSS groups. N 
= 10 and 13/group for Days 6 and 8, respectively and n = 9, 10, 10 and 7 for SED/H2O, 
FTR/H2O, SED/DSS and FTR/DSS, respectively for Day 12. 
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Figure 6. Effects of FTR and DSS on colonic CCL6 (a) and CXCL1 (b) gene expression. 
*denotes significant DSS-induced difference; + indicates a significant difference between 
FTR/H2O and SED/H2O groups. FTR: n = 10 and 13/group for Days 6 and 8, respectively and n 
= 9, 10, 10 and 7 for SED/H2O, FTR/H2O, SED/DSS and FTR/DSS, respectively for Day 12.  
Figure 7. Effects of FTR and DSS on colon histology. Representative (at 5x magnification) 
hematoxylin and eosin stained images (4a-4d, for SED/H2O, FTR/H2O, SED/DSS and FTR/DSS 
at disease peak Day 8, respectively). E, I and N, signify edema, inflammation, and necrosis, 
respectively. Quantification of images for percent necrotic tissue (4e) and inflammation (4f) 
scores (see methods for details). *denotes significant DSS-induced difference vs. SED/H2O; + 
indicates a significant difference between FTR/H2O and SED/H2O groups. n = 10 and 13/group 
for Days 6 and 8, respectively and n = 9, 10, 10 and 7 for SED/H2O, FTR/H2O, SED/DSS and 
FTR/DSS, respectively for Day 12. 
Figure 8.  Effects of prior VWR training on body weight loss (a) and reduction in fluid 
intake (b) induced by DSS treatment. While DSS induced significant weight loss (*) on Days 
6 and 7, there was no time x intervention x treatment interaction. Fluid intake was also depressed 
by DSS at Day 6, but there was no time x intervention x treatment interaction. N = 5, 5, 8 and 8 
for SED/H2O, VWR/H2O, SED/DSS, VWR/DSS, respectively. 
Figure 9. Colon cytokine gene expression in response to DSS in sedentary and VWR 
trained mice. a) IL-1β, b) TNF-α, c) IL-6, d) IL-17, and e) IL-10). *denotes significant DSS 
main effect; + indicates an intervention main effect; # denotes significant intervention x 
treatment interaction. N = 5, 5, 8 and 8 for SED/H2O, VWR/H2O, SED/DSS and VWR/DSS, 
respectively. 
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Figure 10. Effects of VWR and DSS-induced colonic CCL6 and CXCL1 gene expression. a) 
CCL6 b) CXCL1. *denotes significant treatment effect. N = 5, 5, 8 and 8 for SED/H2O, 
VWR/H2O, SED/DSS and VWR/DSS, respectively. 
Figure 11. Effects of VWR on DSS-induced colon histopathology. Representative (at 5x 
magnification) hematoxylin and eosin stained images (8a-8d, for SED/H2O, FTR/H2O, SED/DSS 
and FTR/DSS at disease peak Day 8, respectively). LN, GE and AM signify normal lymphoid 
nodule, glandular elongation and atrophied mucosa due to loss of goblet cells, respectively. 
Quantification of images for percent necrotic tissue (8e) and inflammation (8f) scores (see 
methods for details). *denotes significant DSS-induced difference vs. SED/H2O. N = 5, 5, 8 and 
8 for SED/H2O, VWR/H2O, SED/DSS and VWR/DSS, respectively. 
Figure 12. Effects of FTR and VWR on adrenal and thymic weight. a) adrenal weight and b) 
thymic weight. *denotes significant difference in exercise vs. sedentary. n = 10/group for FTR 
cohort and n = 5/group in VWR cohort.  
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Table 1. Morbidity Outcomes             
   Diarrhea   Diarrhea 
 
Day SED/H2O VWR/H2O SED/DSS VWR/DSS 
 
SED/H2O FTR/H2O SED/DSS FTR/DSS 
 
4 0 0 0 0  
0 0 0 6.1 
 
5 0 0 100 87.5  
0 0 39 30 
 6 0 0 100 50 * 0 0 57 63.6 
 7 0 0 100 37.5 * 0 0 47.8 91.3 * 
8 0 0 75 37.5  
0 0 34.8 73.9 * 
9 
  
 
0 0 30 100 * 
10  
0 0 30 12.5 
 
11  
0 0 10 12.5 
 
12  
0 0 0 14 
 
 
Fecal Hemoccult 
 
Fecal Hemoccult 
 
 
SED/H2O VWR/H2O SED/DSS VWR/DSS 
 
SED/H2O FTR/H2O SED/DSS FTR/DSS 
 
4 0 0 0 0 
 
0 0 0 0 
 
5 0 0 0 0 
 
0 0 0 0 
 6 0 0 50 25 
 
0 0 12.1 8.7 
 
7 0 0 37.5 25 
 
0 0 17.4 21.7 
 8 0 0 12.5 12.5 
 
0 0 21.7 34.8 
 
9 
  
 
0 0 10 12.5 
 
10 
 
0 0 0 12.5 
 
11 
 
0 0 0 12.5 
 
12   0 0 0 12.5 
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CHAPTER 5 
FORCED TREADMILL TRAINING INCREASES MACROPHAGE PRESENCE IN THE 
COLON WHILE VOLUNTARY WHEEL TRAINING BENEFICIALLY ALTERS 
INTESTINAL MICROBIOTA  
5.1 INTRODUCTION  
As a result of preliminary studies, we reported a significant effect of forced treadmill 
training (FTR) on Ccl6 expression in colonic tissue (see CHAPTER 4). Briefly, the chemokine 
CCL6 is chemotactic for innate immune cells (e.g. macrophages) in the colon. Just as important, 
it is an anti-microbial peptide produced by intestinal epithelial cells and is secreted directly into 
the lumen, binds bacteria, and facilitates their inactivity/removal therefore altering microbiome 
characteristics (11). Consequently, we proposed to examine the effects of FTR and voluntary 
wheel running (VWR) on macrophage presence in the colon (Aim 1) and bacterial presence of 
lactobacilli (Aim 2). 
Regular physical activity results in improved immunity, decreased incidence of 
inflammatory disease, and reduces biomarkers of disease activity during disease states (e.g. IBD, 
cancer, colon cancer) (7, 145, 146). Specifically, exercise directly and beneficially affects 
immune cell function in the colon (10, 96, 122, 147). However, there is not enough known about 
the effect exercise training may have on homeostatic effector immune cell presence in the colon. 
In fact, to our knowledge, there has been no information on the effect exercise training may have 
on colonic resident effector immune cell populations (e.g. macrophages). We hypothesized that 
the increased expression of Ccl6, as a result of FTR, may contribute to increasing the 
homeostatic macrophage population ultimately instigating the exaggerated immune response we 
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witnessed in response to DSS. This study will be the first to report the effect of exericse on the 
resident macrophage presence in the colon.  
Intestinal microbial diversity is essential for healthy colonic function, which makes it 
necessary to examine microbiome characteristics during homeostasis and disease states. 
Understanding the interaction between the intestinal microbiome, host colonic cells, and immune 
cells is important. Intestinal homeostasis is maintained by innate and adaptive immune responses 
that are orchestrated through interactions between primary effector immune cells (i.e. 
macrophages), beneficial bacterial metabolites (e.g. butyrate) (148), and the bacteria that produce 
those metabolites (e.g. Lactobacillus) (20). Therefore, considering the role of the microbiota 
during intestinal inflammation is critical (102, 103) since we know dysbiosis (unbalanced 
microbial interactions and immune responses) is a major contributor to IBD (101, 149). During 
times of intestinal inflammation, the primary immune response is toward the commensal bacteria 
where bacteriocidal products from effector immune cells are responsible for killing pathogenic 
bacteria. However, these products also are damaging to the protective mucosal layer (43, 150). 
Due to these processes, it is important to examine whether beneficial bacteria are altered in 
response to exercise or an inflammatory insult in the colon. 
The billions of bacteria present in the colon are representative of multiple genera that are 
beneficial under homeostatic conditions. They provide key nutrients, metabolize carcinogens, 
and interact with the intestinal epithelial layer to regulate innate immunity (151), however they 
can also become opportunistically pathogenic during times of inflammation (21). Experimentally 
altering gut microbiota has significant effects on inflammation in the colon (152). Fortunately, 
there are beneficial bacteria that ‘police’ the microbiota (20) and are anti-inflammatory during 
times of insult (e.g. Lactobacillus) (19, 153). Lactobacilli have been shown to improve barrier 
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function in intestinal disorders (153, 154). Multiple species of this genera have been used to 
effectively treat symptomology associated with irritable bowel syndrome (155), diarrhea (156), 
and ulcerative colitis (157). Unfortunately, certain species (e.g. L. reuteri) have been reported to 
be reduced by chronic stress which would adversely effect immune responses (13), thus making 
Lactobacilli relevant to examine in our exploration of FTR and VWR effects on colon 
inflammation in this model. We believe that FTR would reduce lactobacilli bacterial presence 
because this training modality is considered a chronic stressor and lactobacilli can be negatively 
effected by stress. With respect to VWR, Matsumoto et al. (158) and Choi et al. (159) have 
recently reported that voluntary wheel running alters microbiome characteristics in rats and mice. 
For example, Matsumoto’s group reports increased production of butyrate in the cecum of rats 
after 5 weeks of VWR while Choi et al. found that the microbial community, after 5 weeks of 
voluntary wheel exposure, consists of significantly greater quantities of Lactoacillales. Thus, we 
anticipated that lactobacilli bacterial levels would be sustained or increased after VWR in our 
mouse model. With these results, we are able to add to this body of literature and report the 
effects of forced treadmill training and voluntary wheel training on lactobacilli bacterial presence 
in the colonic mucosa of dextran sodium sulfate (DSS) treated mice.  
5.2 RESULTS 
5.2.1 Effects of FTR and VWR on macrophage presence in colon sections 
Macrophages present in the gut lamina propria are known to highly express the transmembrane 
biomarker F4/80 (160). Therefore we examined the presence of macrophages (F4/80
+
) in cross-
sections of colon tissue with the belief that the increased Ccl6 expression found after FTR would 
be reflected by a greater number of resident macrophages after the training. We found a 
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significant difference in macrophage presence in control vs. trained mice (intervention main 
effect: F2,11 = 10.1, p = 0.003). FTR mice exhibited significantly greater numbers of 
macrophages per cross sectional area (µm
2
) than sedentary (t7 = 3.62 p = 0.008*) and VWR mice 
(t8 = 3.44, p = 0.009#) (SED/H2O: 9.87 ± 2.92, n = 4; VWR/H2O: 13.7 ± 1.96, n = 5; FTR/H2O: 
25.5 ± 3.06, n = 5; data reported as mean ± SEM of macrophage numbers per µm
2
) (Figure 13). 
Macrophage presence was not different between SED/H2O and VWR/H2O mice. 
Respresentative images (40x magnification) can be found in Figure 14.  
 5.2.2 Effects of FTR and DSS on total lactobacilli abundance in colon mucosal 
scrapings 
 Total lactobacilli presence in colon mucosal scrapings was measured 24 hours after the 
last exercise training bout was completed and at Day 8 in both sedentary and FTR mice. 
Surprisingly, DSS treatment resulted in a significant increase in the total lactobacilli content in 
both groups at Day 8 (treatment: F1,36 = 14.55, p = 0.001*) (Figure 15). We observed no 
significant change in lactobacilli abundance in FTR mice when compared to their sedentary 
counterparts (SED/ H2O = 1.0 ± 0.03; FTR/H2O = 0.74 ± 0.15: data reported as mean ± SEM 
fold expression) (t17 = 1.8, p = 0.095).   
 5.2.3 Effects of VWR and DSS on total lactobacilli abundance in colon mucosal 
scrapings 
 Total lactobacilli presence in mucosal scrapings were measured in VWR trained mice 24 
hours after their last exercise bout, at disease peak in sedentary and VWR mice (VWR1/DSS), 
and in mice that were allowed unlimited access to wheels (VWR2/DSS) before and during DSS 
treatment until euthanization at day 8. There was not a significant treatment effect of DSS in this 
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group of mice. The DSS effect was diminished, as evidenced by a significant intervention x 
treatment interaction (F1,28 = 15.03, p = 0.001*) (Figure 16a), where there was a 6-fold greater 
expression of total lactobacilli DNA in VWR/H2O mice over SED/H2O (t13 = 5.9, p = 0.004#) 
and FTR/H2O groups (t13 = 5.9, p = 0.004%) (Figure 16b). In mice that were allowed to have 
access to their wheels during the experiment (VWR2/DSS, n = 8), we observed an increase (not 
statistically significant; t13 = 1.4, p = 0.18) in total  lactobacilli abundance when compared to 
mice that had their wheels locked after 30 days of training (VWR1/DSS, n = 7) ( VWR/DSS1: 
2.24 ± 0.31; VWR/DSS2: 3.80 ± 1.0; mean ± sem fold expression over SED/H2O referent group) 
(Figure 16c). 
Exercise training (FTR and VWR) and DSS treatment significantly altered the total 
amount of bacterial DNA present in the colon mucosal scrapings. Compared to SED/H2O 
controls,  both intervention (FTR and VWR) (intervention: F5,54 = 13.67, p < 0.001#) and DSS 
treatment groups (treatment: F5,54 = 16.52, p < 0.001*) expressed a decrease in total bacterial 
content as evidenced by increased critical threshold values (CT values) from qPCR (Figure 
16d).  
5.2.4 Effects of DSS on bacterial translocation to mesenteric lymph nodes (MLN’s) 
 To test our hypothesis that the 3 FTR/DSS mice from our recovery study died from 
bacterial translocation and subsequent systemic infection, we harvested MLN’s from control 
(H2O) and DSS treated sedentary and exercised mice. We were unable to detect any bacterial 
DNA in the MLN’s harvested from water or DSS treated mice at Day 8 (FTR/H2O, SED/DSS, 
FTR/DSS, or VWR/DSS) and conclude that FTR and DSS treatment is not responsible for 
bacterial translocation to MLN’s, at least at Day 8 in these mice. 
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5.3 DISCUSSION 
 Results from these studies show that forced treadmill running (FTR) increases while 
voluntary wheel running (VWR) does not significantly affect the population of resident 
macrophages in the colon (Figures 13-14). Although stress has been reported to instigate 
bacterial translocation to the MLN’s (23), there was no evidence to suggest that FTR or DSS 
treatment is responsible for bacterial translocation in our model at day 8. We were able to 
determine that intestinal microbiota are not significantly altered by FTR but definitely improved 
by VWR. These data show that FTR does not change (Figure 15), while VWR significantly 
increases (Figure 16a) total lactobacilli presence in the colonic mucosa and this reveals a 
potential mechanism for the protective effect VWR has in this model of colitis. Additionally, 
both exercise training and DSS treatment affects mucosal microbiome characteristics by 
reducing the total amount of bacterial DNA detected (Figure 16d). 
Immunohistochemical analysis of macrophage presence (F4/80
+
) in FTR and VWR 
trained mice revealed that homeostatic macrophage presence is significanlty increased as a result 
of FTR. This result confirms our hypothesis and allows us to determine that greater effector 
immune cell presence, as a result of FTR, is likely a main contributor to the exacerbated pro-
inflammatory cytokine production and greater symptomology observed in FTR/DSS mice. This 
finding has significant clinical relevance as highly trained endurance athletes, who suffer with 
inflammatory gastrointestional disorders, may benefit from new and improved treatment 
strategies if an overpopulation of homeostatic effector immune cells (i.e. macrophages) is a 
result of their training. Future studies are needed to confirm if this phenomenon occurs in 
humans.   
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Although we were unable to detect bacterial DNA in the MLN’s of DSS treated mice, we 
were unable to harvest tissues from the 3 FTR/DSS mice that died and therefore cannot conclude 
that they did not experience systemic infection through bacteria translocation. It would be 
beneficial to determine if DSS promotes bacterial translocation to secondary lymphoid organs 
earlier (i.e. Day 6) or after Day 8.  
Lactobacilli have beneficial properties that support colon health and immune function 
(19, 20, 161). We speculate that the significantly greater presence of these bacteria during this 
inflammatory insult may be a  microbiome compensatory mechanism to aid in reducing 
inflammation by potentially increased butyrate production (162), reducing NF-kB activation and 
pro-inflammatory cytokine production by intestinal epithelial cells (151) and macrophages (153), 
and/or restoring mucosal barrier function by reducing the colonization and potential translocation 
of opportunistic pathogens (20). This finding could explain the “resistance” to DSS-induced 
colitis observed in VWR mice. Interestingly, sedentary and FTR DSS treated mice exhibited 
about a 2-fold increased presence of lactobacilli over VWR1/DSS mice (Figures 15-16a). One 
could assume that these opposable modes of training, and their differential inflammatory 
responses to DSS, are behind this response from these beneficial bacteria. As inflammation is 
significantly lower in VWR mice, lactobacilli do not have to expand their presence to the same 
extent as sedentary and FTR mice. While lactobacilli may be significantly participating in the 
recovery of barrier function and dampen inflammation in FTR trained mice, these bacteria may 
play more of a maintenance role during the inflammatory response in VWR mice. Interestingly, 
mice that were allowed to continue to exercise throughout the entire study exhibited a greater 
expression of total lactobacilli bacterial content on day 8 (Figure 16c). This implies that if 
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exercise can be tolerated during disease activity, it may have an even greater beneficial effect on 
intestinal mucosal microbiome characteristics.  
We found that total bacterial content was decreased by both FTR and VWR training and 
DSS treatment which is evidenced by a significant increase in the critical threshold (CT) values 
in 16S rDNA in all intervention and treatment groups (Figure 16d). The decrease we observed in 
total bacterial DNA makes it difficult to determine whether the increase in total lactobacilli 
content is a result of increased expansion of lactobacilli or just a higher percentage of lactobacilli 
within the total amount of bacteria overall. However, recent findings by Choi et al. (159) 
document specific changes in different orders of bacteria with VWR. They report that VWR was 
responsible for 67 taxa of bacteria being unique to trained mice with approximately 40 of these 
belonging to the order Lactobacillales. Therefore, it is likely that we observed the same 
phenomenon in our study with VWR.  
However with DSS, Nagalingam et al. (163) reported that 5% DSS treatment for only 3 
days results in reduced diversity in the microbial community in the cecum without affecting the 
absolute bacterial load, while Heimesaat et al. (164) reported that 3.5% DSS treatment was 
responsible for increasing Gram-negative bacteria strains (e.g. E. coli) in the intestinal 
microbiota, which were responsible for exacerbated inflammation in their experimental groups 
with no changes detected in the number of lactobacilli. Our data demonstrate that 5 days of 2% 
DSS treatment, 30 sessions of FTR and 30 days VWR training does affect the absolute 
abundance of bacteria in the mucosa of the proximal colon and differentially alters lactobacilli 
content across groups (Figures 15 and 16). Differences in microbiome characteristics may be 
explained by differences in length of time and concentration of DSS treatment between these 
studies and our own, as well as anatomical differences where bacterial populations were 
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harvested (cecum vs. distal colon luminal fecal samples vs. mucosal scrapings of the proximal 
colon). None-the-less, our results provide a potential mechanism (↑ lactobacilli content in the 
colon mucosa) for the protective effect of VWR in DSS-induced colitis that needs to be further 
explored.  
These data strongly imply the need to investigate: 1) the effect of elite endurance trained 
status on effector immune cell presence in the colon of humans and the relation to 
gastrointestinal symptoms exhibited; 2) whether habitual exercise affects intestinal microbiome 
characteristics in humans; and 3) if habitual moderate exercise, coupled with probiotic 
supplementation as adjunctive therapy, positively affects morbidity and remission of symptoms 
in ulcerative colitis.    
5.4 FIGURE LEGENDS AND FIGURES 
Figure 13. Effects of FTR and VWR on macrophage presence in colon sections. Results are 
reported as macrophage number per cross sectional area of colon tissue. * denotes significant 
difference from SED/H2O and # denotes significant difference from VWR/H2O. SED/H2O, n = 
4; VWR/H2O, n = 5; FTR/H2O, n = 5) 
Figure 14. Effects of FTR and VWR on macrophage presence in colon sections. Slides a 
(SED/H2O), b (VWR/H2O), and c (FTR/H2O) are representative colon cross-sections (3µm; 40x 
magnification) probed for macrophage (F4/80
+
) cells. Slide d shows a representation of lamina 
propria macrophages and lymphocytes in a FTR/DSS cross section. SM = smooth muscle, LP = 
lamina propria, Mo = macrophages, GC = goblet cells, C = colonocytes, LPc = lamina propria 
cells (consisting of fibroblasts, epithelial cells, lymphocytes, stromal cells). 
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Figure 15. Effects of FTR and DSS on Total lactobacilli presence in mucosal scrapings. Results 
are reported as relative fold expression from the SED/H2O referent group. * denotes significant 
treatment effect. (SED/H2O n = 10; FTR/H2O, n = 9; SED/DSS, n = 10; FTR/DSS, n = 10) 
Figure 16 a-d. Effects of VWR (b) and DSS (a & c) on Total lactobacilli presence in mucosal 
scrapings and total bacterial presence (16S rDNA) in colon mucosal scrapings (d). Results are 
reported as relative fold expression from the SED/H2O referent group. * denotes significant 
intervention x treatment interaction, # denotes significant difference over SED/H2O, % denotes 
significant difference over FTR/H2O. In Figure 16d, # denotes significant intervention effect 
while * denotes a significant treatment effect. (SED/H2O n = 10; VWR/H2O, n = 5; FTR/H2O, n 
= 9; SED/DSS, n = 10; FTR/DSS, n = 10; VWR1/DSS, n = 7; VWR2/DSS, n = 8). 
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CHAPTER 6 
CONCLUSIONS AND FUTURE DIRECTIONS 
 The overaching aims of these studies were to mechanistically investigate the causes of 
exacerbated inflammation in force treadmill trained (FTR) mice and examine if voluntary wheel 
training (VWR) elicits the same results as FTR during DSS-induced colitis. We found that FTR 
exacerbates the inflammatory response to DSS colitis and present evidence that it is a chronic 
stressor. We observed a 30% mortality rate in FTR mice after DSS treatment and FTR mice 
exhibited pathologic measures of chronic stress (adrenal hypertrophy and thymic involution). 
With this, we further discovered that FTR exerts a significant effect on effector immune cells by 
increasing colonic resident macrophage presence. We conclude that the these factors are major 
contributors to the exacerbated inflammatory gene expression response to DSS observed in this 
group.  
 VWR reduced inflammatory gene expression at disease peak (Day 8) and sped recovery 
from DSS induced colitis. The volume of exercise was exponentially greater than that performed 
in FTR mice (CHAPTER 4) but VWR mice presented with a significantly greater abundance of 
mucosal lactobacilli in the colon and a significantly reduced number of colonic macrophages 
after training compared to FTR mice. These effects, on effector immune cell presence and 
enriched mucosal microbiome characteristics, are more than likely key contributors of VWR’s 
ability to aid in protecting mice from disease activity associated with DSS-induced colitis.   
 It is important to further investigate some important questions that these data reveal. 
Future research should be conducted to examine the following: 
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1. Is there an exercise threshold necessary to elicit the anti-inflammatory effects of training 
in the colon of DSS treated animals? Its important to know if the volume of exercise was 
too little in FTR mice to obtain any protective effect. 
2. Better characterize the effects of FTR and VWR on intestinal microbiome characteristics 
by examining other beneficial bacterial genera, measuring production and/or 
manipulating levels of their anti-inflammatory products (e.g. short chain fatty acids such 
as butyrate) to elucidate if these are key in regulating the inflammatory response to DSS 
in VWR mice. 
3. Identify an appropriate marker of dendritic cells for immunohistochemical analysis of 
their presence in the colon, since Ccl6 may also affect the resident homeostatic 
population of dendritic cells in the colon. In addition, utilizing other techinques (e.g. flow 
cytometry) to comprehensively analyze the different populations of effector immune cells 
(e.g. macrophages, dendritic cells, neutrophils, regulatory T lymphocytes) present in the 
colon after training and in response to DSS. 
4.  Propose and perform human interventional studies to investigate the effects of habitual 
moderate exercise on the intestinal microbiome and ulcerative colitis disease activity.  
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APPENDIX 
Acute Forced Treadmill Exercise during DSS-Induced Colitis 
Significance and Rationale 
One caveat of exercise training during IBD, when disease activity is high, is that the 
debilitating side effects of intestinal inflammation are responsible for intestinal cramping, 
frequent and uncontrollable diarrhea, and intestinal bleeding. Therefore it is difficult for 
individuals to perform prolonged endurance exercise. Due to this, it is common medical practice 
for physicians to advise patients against prolonged exercise during times of significant disease 
activity, as it is thought that exercise may exacerbate the patient’s symptoms (6). Although 
limited, studies suggest that exercise reduces the severity of local and systemic symptoms during 
that time (6).  
Therefore, we performed an acute forced treadmill (FTR) exercise study where we 
examined colon inflammatory status during DSS-induced colitis in sedentary C57/Bl6J mice at 
10 weeks of age. In this experiment, 32 animals were used (SED/H2O, FTR/H2O, SED/DSS, 
FTR/DSS: n=8/group) and mice were acclimated to treadmill exercise for three non-consecutive 
days for 10-20 min. The following week, we induced colitis by 2% DSS in drinking water for 5 
days in sedentary and concurrently treadmill exercised mice (8-12 m/min; 30 – 40 min; 
n=8/group).  Although difficult for some animals, all mice performed exercise for at least 30 
minutes up to day 5. There were only four mice that were able to run at least 15 minutes on Day 
6. Only 2 mice ran 20 minutes on Day 7. Mice were euthanized on Day 8 (see CHAPTER 3 for 
methodology).   
RESULTS 
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Effects of FTR on DSS-induced changes on morbidity.  
Body weight loss, food and fluid intake. DSS treatment resulted in significant weight loss 
beginning at Day 6 onward in both treated groups (time x treatment: F7,22 = 8.098; p < 0.001) 
(Figure 17a). There was no difference between SED/DSS and FTR/DSS in body weight (time x 
treatment x intervention: F7,22 = 0.280; p = 0.955). Food intake data was only analyzed up until 
day 7 because mice were fasted for 8 hours prior to Day 8 euthanasia. Over the seven days, food 
intake was significantly altered by DSS (time x treatment: F6,168 = 6.371; p < 0.001) and there 
was a time x intervention x treatment interaction (F6,168 = 4.503; p = 0.004) where FTR/DSS 
mice food intake began to rebound on Day 5 while SED/DSS mice exhibited a continual decline 
in food intake on Days 6 and 7 (p < 0.05) (Figure 17b). For fluid intake in this experiment, DSS 
sharply reduced fluid intake (time x treatment: F 7,196 = 64.15; p < 0.001) which occurred on Day 
5. There was also a time x intervention x treatment interaction (F 7,196 = 10.196; p < 0.001) where 
FTR mice had a slightly increased rebound in fluid intake on Days 6 and 7 compared to 
SED/DSS mice. (Figure 17c).  
 Diarrhea Incidence. DSS was responsible for diarrhea on Days 5-7 post-DSS. There 
were no significant differences in diarrhea incidence between the two DSS groups. Figure 18 
shows diarrhea incidence as a percent incidence within each group. Diarrhea occurred most 
frequently at Day 7 post-DSS with 87.5% (7 of 8) of the mice in both groups presenting with this 
symptom. There was no diarrhea detected in any of the H2O control groups. 
Effects of FTR colon cytokine gene expression.  
As expected, DSS increased pro-inflammatory cytokine gene expression in the colon 
(treatment: IL-1β: F1,28 = 12.21; p=0.002:  TNF-α: F1,28 = 23.37; p<0.001: IL-6: F1,28 =6.121; 
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p=0.02: IL-10 F1,28 = 9.98; p=0.004)  (Figure 19 a-d). However, there were no intervention x 
treatment interactions for any of the inflammatory cytokine genes. These results provide 
evidence that forced treadmill exercise during colitis induction does not exacerbate colon 
inflammation as we have witnessed in our training model. 
CONCLUSION 
 Contrary to the results of our FTR training experiments, the results of this experiment 
suggest that performing moderate exercise at the onset of intestinal inflammation and throughout 
does not exacerbate symptoms of colitis. It is interesting to note the faster rebound in food and 
fluid intake in FTR mice, which would suggest that exercised mice are rebounding from 
symptoms, and may ultimately resolve colon inflammation faster. However, this study does not 
address whether exercise, past disease peak (e.g. past Day 8), negatively or positively affects 
colon inflammation in this model. Certainly, if FTR is perceived as a stressor, as suggested by 
our model of treadmill training (see CHAPTER 4 Manuscript Figure 9a-b), there could be an 
exacerbation or even delayed recovery from inflammation in the colon past Day 8. Pathological 
measures of stress (adrenal hypertrophy and thymic involution) and microbiome characteristics 
(total Lactobacilli presence) may aid in this determination. Unfortunately, we are not able to 
address that in this study.  
FIGURE LEGENDS AND FIGURES 
Figure 17. Body weight (a), food intake (b), fluid intake (c). * denotes significant treatment 
difference, # denotes significant difference between SED/DSS and FTR/DSS groups on Days 6 
and 7 (p < 0.05). 
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Figure 18. Diarrhea incidence. On Days 5 – 7, where animals exhibited diarrhea. There were no 
significant statistical differences between sedentary and FTR mice in this experiment. On Day 5, 
1 out of 8 mice exhibited diarrhea in each group. On Day 6, SED/DSS group had 5 of 8 mice 
exhibit diarrhea while 4 of 8 did in the FTR/DSS group. On Day 7, 7 of 8 mice in each group had 
diarrhea. Mice were fasted on 8 hours prior to sacrifice on Day 8. Therefore, there was no fecal 
material present to test for diarrhea. 
Figure 19. Acute FTR inflammatory cytokine gene expression. a) IL-1β gene expression, b) 
TNF-α gene expression, c) IL-6 gene expression, d) IL-10 gene expression in colon tissue at Day 
8 (disease peak) (n = 8/group). 
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ADDITIONAL EXPERIMENT RESULTS 
Gastrocnemius citrate synthase activity was measured in the sedentary and FTR mice to 
provide evidence of a training effect. Figure 20 shows that citrate synthase activity 
(µmol/CS/g/min) was significantly increased in the right gastrocnemius muscle of FTR mice 6, 
8, and 12 days after training.  
Other inflammatory genes were examined in Day 8 FTR mice that were not reported in 
CHAPTER 4. IL-23, a promoter of Th17 responses and suppressor of IL-10 (165), was higher in 
the FTR group at Day 8 (F1,48 = 8.8, p = 0.005*) (Figure 21a), but there were no intervention or 
intervention x treatment effects. IL-12, a cytokine that is involved in the differentiation of naïve 
T-cells to Th1 cells, is produced by dendritic cells and macrophages. We found that its 
expression was significantly elevated by DSS treatment (F1,48 = 20.6, p < 0.001*) (Figure 21b), 
but there was no effect of FTR or an interaction. TGF-β, a cytokine that promotes cellular 
proliferation and differentiation in immune cells, is highly expressed in many tissues and also 
highly correlated with ulcerative colitis disease activity in humans (166). We examined relative 
mRNA levels at Day 8 in FTR mice and found that its expression did not change in response to 
training or DSS treatment (Figure 21c). Lastly, we examined Cxcl12 expression in colon tissue. 
This chemokine is constitutively expressed by intestinal epithelial cells, can regulate lymphocyte 
infiltrate into the lamina propria, and is highly expressed in patients with IBD (167). Figure 21d 
shows that Cxcl12 expression is not altered by DSS treatment but there is a slight increase in its 
mRNA expression, in the FTR groups, that is not statistically significant (intervention: F1,48 = 
3.06, p = 0.086).  
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In efforts to correlate sickness behaviors (reduction in food and fluid intake) and body 
weight changes with inflammation in DSS treated mice, we examined inflammatory cytokine 
expression in the whole brain (Figure 22). In the brain, IL-1 and TNF-α mRNA expression were 
significantly increased in response to DSS treatment at Day 8 (IL-1: F1,48 = 5.71, p = 0.020*; 
TNF-α: F1,48 = 5.93, p = 0.019*) (Figure 22a & b) and there was no significant difference 
between DSS groups. IFN-γ expression in the brain was not significantly altered by DSS 
treatment but tended to be lower in FTR mice (intervention: F1,48 = 2.83, p = 0.09) (Figure 22d). 
However, there was a significant intervention effect on IL-6 expression in the whole brain that 
was driven by a lower relative expression of IL-6 in FTR/DSS mice (intervention: IL-6: F1,48 = 
7.24, p = 0.01*) (Figure 22c).  
Included in the voluntary wheel training study (VWR) was an additional group that was 
allowed free access to their wheel during DSS treatment until Day 8 (VWR1/DSS = wheel 
locked at the start of DSS; VWR2/DSS = free access to wheel until euthanization at Day 8). 
There was no difference in body weight up to Day 8 between VWR1/DSS and VWR2/DSS (F1,14 
= 0.742, p = 0.637). Inflammatory gene and chemokine expression was also not different 
between the two groups (IL-1β: t13 = -0.097, p = 0.924; TNF-α: t13 = 0.032, p = 0.975; IL-6: t13 = 
-0.006, p = 0.995; IL-17: t13 = -0.113, p = 0.911; IL-10: t13 = -0.264, p = 0.796; CCL6: t13 = 
0.022, p = 0.982) (Figure 23a-f).  
FIGURE LEGEND AND FIGURE 
Figure 20. Gastrocnemius Citrate Synthase Activity is represented here. FTR mice had 
significantly increased citrate synthase activity compared to sedentary mice. * denotes significant 
intervention effect (p < 0.05).  
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Figure 21. Effects of FTR and DSS on cytokine and chemokine mRNA expression at Day 8. (a) 
IL-23, (b) IL-12, (c) TGF-β, (d) Cxcl12. * denotes significant treatment effect, (n = 13/group). 
Figure 22. Effects of FTR and DSS on inflammatory cytokine mRNA expression in whole brain 
at Day 8. (a) IL-1β, (b) TNF-α, (c) IL-6, (d) IFN-γ. * denotes significant treatment effect and # 
denotes a significant intervention effect, (n = 13/group). 
Figure 23. Effects of continued VWR on inflammatory cytokine and chemokine mRNA 
expression in the colon at Day 8. VWR1/DSS = locked wheel and VWR2/DSS = non-locked 
wheel. (a) IL-1β, (b) TNF-α, (c) IL-6, (d) IL-17, (e) IL-10, (f) CCL6. SED/H2O, n = 5; 
VWR/H2O, n = 5; VWR1/DSS, n = 7; VWR2/DSS, n = 8. 
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